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ABSTRACT 
Serial transplantation of bone marrow through irradiated 
syngeneic hosts resulted in a decline in the capacity of haematopoietjc 
stem cells to (a) self-renew, and (b) regenerate the haematopoietic 
system of lethally irradiated mice. Repeated regeneration of the 
stem cell pool in situ following serial injections of hydroxyurea, 
however, did not result in any decline in stem cell function. A 
decreased immune responsiveness was observed in mice repopulated 
with serially transplanted bone marrow. An attempt was made to 
detect protein-synthetic errors in reticulocytes descended from 
serially transferred stern cells by measuring the heat-labile 
fraction of glucose-6-phosphate dehydrogenase. No increase 
in altered enzyme was observed. 
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GENERAL INTRODUCTION 
The mature cells of the blood are a highly differentiated 
population with a relatively short life-span. With the exception of 
lymphocytes, mature blood cells are incapable of proliferation and are 
constantly replenished from haematopoietic progenitor cells, The 
stem cells responsible for the maintenance of renewing systems are, 
by definition, capable of extensive proliferation resulting in 
self-renewal as well as the synthesis of differentiated end cells 
(Lajtha et al 1962, Becker et al 1963). There is general agreement 
that mammalian differentiated blood cells are descended from a common 
ancestor cell, the haematopoietic stem cell (Metcalf & Moore 1971). 
Haematopoietic stem cells are not identifiable morphologically but 
Till and McCulloch (1961) described a technique which allows the 
enumeration of a population of primitive haernatopoietic cells which 
possess the characteristics of stem cells. These cells, which are 
both self-maintaining (Till et al 1964) and pluripotent (Wu et al 
1967, 1968), form macroscopic colonies in the spleens of irradiated 
recipients and are known as spleen colony forming units (CFU-S). 
Spleen colonies are monoclonal in origin (Becker et al 1963, 
Chen & Schooley 1968) and exhibit three main lines of haematopoietic 
differentiation; erythroid, granulocytic and megakaryocytic. 
Individual spleen colonies may be of a single line of differentiation 
or mixed (Fowler et al 1967). Approximately 8GW. of surface colonies 
are erythroid (Lewis et al 1968). 
Since spleen colonies are monoclonal it is possible to 
calculate the number of CFU-S in haematopoietic organs. However, 
only a fraction of the CFU-S injected come to rest in the 
spleen. The seeding factor, f, is determined from secondary 
transplantation of primary recipient spleens at intervals after 
inoculation of the stem cell suspension, and has been variously 
estimated at between 0.03 and 0.25 (Siminovitch et al 1965, 
Schooley 1966, Fred & Smith 1968, Lahiri & Van Putten 1969, 
Hendry 171). 
In the adult mouse CFU-S are present in the highest frequency 
in the marrow. Fewer CFU-S are found in the spleen and small numbers 
of circulating CFU-S can be detected in the blood (Metcalf & Moore 
1971). Most CFU-S are normally in a quiescent state, either in 
or prolonged G 1 . The proportion in cell cycle can rise greatly in 
response to haematopoietic demand (Becker et al 1965). 
The spleen colony assay, therefore, allows the investigation 
of a population of haematopoietic cells with the characteristics 
of stem cells. It does not, however, follow (as is sometimes 
supposed) that CFU-S and haematopoietic stem cells are synonymous. 
Not all CFU-S can be regarded as stem cells since populations of CFU-S 
exist which fail to self-renew (Micklem et al 1975); nor is there any 
proof that all stem cells form spleen colonies. Rosendaal et al 0976) 
have shown that the most potent stem cells are those which are most 
resistant to whatever mitogenic stimulus affects stem cells at times 
of haematopoietic crisis. It is possible to conceive of a population 
of 'powerful' haematopoietic stem cells that are so refractory that 
they fail to form spleen colonies. 
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However, with these limitations in mind, the haematopoietjc system 
by virtue of the spleen colony assay, provides a good model for 
the study of the stem cells of a continuously renewing system. One 
aspect of such systems that has been the subject of speculation, 
is the extent to which continous regeneration influences the 
capacity of the stem cells to proliferate. It is well known that 
human diploid fibroblasts cannot be cultured indefinitely (Hayflick 
& Moorhead 1961, Hayflick 1965, Martin et al 1970). Their life in 
vitro can be divided up into three main phases; the setting up of 
the cultures (phase I), normal growth (phase II) and period of 
senescence and ultimate death (phase III). It has been shown 
(Hayflick 1965) that the lifespan of fibroblasts in vitro is more 
closely related to the number of cell or population doublings than 
to chronological age. For human foetal lung fibroblasts Hayflick 
(1965) estimated the potential lifespan as approximately 50 cell 
doublings. There are several pieces of evidence that suggest that 
the finite lifespan of diploid cells in vitro may reflect, at a 
cellular level, ageing of whole organs and cell systems in the 
intact animal. 
It has been reported that the number of population 
doublings that such fibroblasts can undergo is inversely 
related to the age of the donor (Hayflick 1965, Martin et al 
1970). This is most evident between adult and foetal tissue since 
the degree of decline with post-natal age is not very great and 
the scatter between individual results is appreciable. 
There is a marked reduction in the in vitro lifespan of 
fibroblasts from patients with diseases associated with premature 
ageing; Werners syndrome (Martin et al 1970) and progeria 
(Goldstein 1969). 
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(3) The number of in vitro population doublings appears to 
be related to the maximal expected lifespan of the fibroblast donor 
species (Goldstein & Singal 1974). 
Thus, fibroblast cultures have been used extensively to study 
the intrinsic processes of cellular ageing. It can be argued, however, 
that data obtained from in vitro systems may not reflect conditions 
in vivo. That cells may also have a limited lifespan in vivo has 
been implies by the limited growth capacity of mouse mammary 
epithelium (Daniel et al 1968) and skin grafts (Krohn 1962) when 
serially propagated in syngeneic hosts. In addition Krohn's (1962) 
experiments suggested that the growth potential of grafts from 
old donors was reduced compared with that from young donors. A 
similarly limited lifespan in vivo has been described for serially 
transplanted haematopoietic stem cells (Siminovitch et al 1964, 
Micklem & Loutit 1966). The possibility of a direct assay for 
haematopoietic stem cells by the spleen colony technique makes 
the haematopoietic system, on the face of it, a particularly good one 
in which to study the extent to which the lifespan of a cell population 
in vivo is determined by its mitotic history. In the experiments 
described here repeated regeneration of haematopoietic stem cell 
populations was induced either by serial transplantation, or in situ, 
by serial injections of the cycle active drug hydroxyurea. 
CHAPTER ONE 
STEM CELL FUNCTION 
INTRODUCTION 
Absolute numbers of marrow CFU-S show no signs of decline with 
age in the adult mouse (Chen 1971) and may even increase in some 
strains (Metcalfe & Moore 1971). The capacity of CFU-S to self-
renew 	(Heilman et al 1978) or to regenerate haematopoiesis 
(Micklem & Ogden 1976, Harrison 1975) is not affected by donor age. 
There is, however, substantial evidence for a qualitative difference 
between embryonic and adult stem cells. Foetal liver CFU-S are more 
radioresistant (Siminovitch et al 1965) and have a shorter doubling 
time (Kubanek et al 1970, Schofield 1970). Metcalf and Moore (1971) 
serially transplanted spleen CFU-S derived originally from yolk sac, 
foetal liver or adult bone marrow, through irradiated recipients. 
The numbers of transfers achieved before CFU-S renewal ceased was 
greatest in yolk sac stem cells and least in adult bone marrow cells. 
Again, no difference was seen between young and old adult cells. When 
injected into an irradiated recipient, along with adult bone marrow, 
foetal liver stem cells were better able to regenerate haematopoiesis 
(Micklem et al 1972). 
The superiority of foetal stem cells might possibly be 
explained on the basis of their shorter mitotic history since decline 
in the growth potential of fibroblasts in culture has been correlated 
with an increase in their mitotic 'burden' (Hayflick 1965) Metcalf 
and Moore (1971) have suggested that approximately 50 divisions may 
be necessary to generate a full complement of adult stem cells from 
a fertilised ovum. It is therefore conceivable that the increased 
mitotic experience of adult stem cells has resulted in a decrease 
in their regenerative potential. Since most of the stem cells in adult 
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mice are normally in G0 (Becker et al 1965) it is not hard to see 
why the age of the donor has little affect on stem cell function. 
Under conditions of severe haematopoietic demand, however, it may 
be possible to exhaust the proliferative potential of adult stem 
cells. 
The effect of multiple regeneration on haematopoietic stem 
cells can be studied by serial transplantation. A small number of 
bone marrow stem cells is injected into lethally irradiated syngeneic 
recipients and allowed to regenerate the haematopoietic system. 
Later a small proportion of their descendent cells is injected into 
secondary irradiated recipients and so on. The stem cell pool 
necessarily undergoes extensive proliferation at each transfer. 
Results obtained from serial transfer experiments clearly show 
that while murine bone marrow stem cells are capable of maintaining 
haematopoiesis for up to two times the normal life span they cannot 
be transferred indefinitely (Micklem & Loutit 1966, Harrison 1973, 
Siminovitch et al 1964, Cudkowicz et al 1964). Although to a certain 
extent, the time between transplants can lead to increased 
regenerative capacity of descendent stem cells, even intervals of up 
to a year do not allow bone marrow stem cells to repopulate irradiated 
animals beyond the 5-6th transfer (Micklem & Loutit 1966). Lajtha and 
Schofield (1971) were able to maintain normal proliferation of stem 
cells even after the 6th transfer but were unable to distinguish 
between donor and recipient cells. To be able to do so is important 
since some host regeneration may occur after 3-4 transfers and by the 
6th transfer practically all cells may be of host origin (Ogden & 
Micklem 1976). Since only 0.01% of recipient CFU-S, or perhaps 30 in 
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all, would be expected to survive 900 rad (McCulloch & Till 1962), 
and since approximately 1000 CFU-S were injected at the 5th transfer, 
it is evident that the majority of donor CFU-S were by this stage 
capable of generating only very small clones of cells. The number of 
clones contributing to haematopoietic regeneration decreases with 
transfer number (Ogden & Micklem 1976). 
These results suggest that the proliferation capacity of bone 
marrow stem cells, while extensive, is not unlimited. It may be that 
under conditions where stem cells are induced to regenerate 
haematopoiesis repeatedly, they exhibit, in vivo, a finite life span 
of the sort described for fibroblasts in vitro. The following 
experiments were designed to investigate, in more detail, the effects 
of serial transfer on stem cell function. However, since the technique 
of serial transfer involved the removal of stem cells from their 
natural milieu, with accompanying destruction of the haematopoietic 
microenvironment and possible loss of rare or fragile cells , it can 
be argued that experiments of this type bear little relationship to 
haematopoietic regeneration in the intact animal. In a further 
set of experiments it was possible to study the effect of extensive 
stem cell proliferation in situ by giving mice serial injections of 
hydroxyurea, a cycle active drug known to cause haematopoietic 
hypoplasia (Hodgson et al 1975). 
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MATERIALS AND METHODS 
Mice 
3-6 month old female mice of the chromosomally—distinct inbred 
strains, CBA/H, CBA/T6T6 and the F 1 hybrid were used throughout, All 
3 strains are syngeneic but distinguishable in mitotic metaphase by 
the possession of no (CBA), one (T6) or two (T6T6) small marker 
chromosomes (Plate 1). The possession of the marker, a radiation—
induced translocation backcrossed on to the CBA/H strain, confers no 
proliferative advantage (Micklem et al 1975a). 
Irradiation 
Mice received either X-rays from a Westinghouse machine at 
230kv, 15ma at a dose rate of 66 rad/min orYrays from a 
137 
 Cs source 
at a dose rate of 39.28 rad/min ± 3.6%. 
Preparation of cell suspensions 
Bone marrow suspensions were obtained by flushing out the bone 
marrow cavities with ice cold Hanks balanced saline and aspirating the 
marrow plug through a 25g needle to obtain a single cell suspension. 
Spleens were homogenised in ice cold Hanks' balanced saline and 
filtered through wire gauze. 
All cell suspensions were washed once, counted with a haemocyt-
ometer and resuspended in the required volume of Hanks 
Plate 1.1 Chromosome spread from the 
bone marrow of a CBA mice, b(CA x T6T6)P 
mice, c T6T6 mice. Stained with aceto-
orcein. Magnification x 600. 
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Serial transplantation of bone marrow 
Lethally irradiated mice (900 rad) were injected intra-venously 
(IV) with 5 x 
10 
  chromosomally distinct nucleated bone marrow cells 
each. 8 weeks later recipients were killed and 5 x 10 6  of their 
bone marrow cells injected into further lethally-irradiated recipients 
which were likewise killed 8 weeks later for bone marrow transfer and 
so on for up to 6 transfers. 
Injection with hydroxyurea (4U) 
Mice received either of 2 regimes of HU. Control mice were 
given saline. 
2H U 
2 intra-peritoneal (IP) injections of HU (Sigma Chemical Co., 
London) at a dose of lmg/g body weight 7 hours apart (Hodgson et al 
l975)cY€:ve.L 	repeated at 21 day intervals. Stem cell 
activity in the pooled marrow of at least 3 donors was assayed 21 
days after the final pair of injections. 
SHU 
5 IP injections of HULat  the same dose as above at 0,-5,-8,-24 
and-0 hours (Rosendaal et al 1976). 5HU was repeated at 8 week 
intervals. Stem cell activity was assayed 2 hours, 24 hours, 10 days 
and 21 days after the 5th injection. 
Cycling characteristics of CFU-S were determined by giving 1 
injection of I-lU (lmg/g body weight) or cytosine arabinoside (Ara-C: 
Sigma Chemical Co. London) at a dose of 10mg per mouse 2 hours before 
killing. Control mice received saline. 
Spleen colony (CFU-S) assay 
Bone marrow haematopoiet -ic stem cells were enumerated using the spleen 
colony assay of Till and McCulloch (1961). 5 x 10 nucleated bone marrow 
cells were injected IV into lethally—irradiated (900 rad) syngeneic 
mice. 8 or 10 days later the mice were killed, their spleens fixed in 
Bouins fixative and the macroscopic surface colonies counted. The 
results were expressed as the mean number of colonies/10 5 injected cells 
for 5-10 mice pergroup (CFU ratio). A control group received no cells. 
For assay of circulating stem cells peripheral blood nucleated cells 
were first separated from erythrocytes on Plasmagel (Labatoire Roger Beflon) 
before injection into irradiated recipients. 
Assay of spleen colony renewal 
5 x 10 cells were injected into lethally-irradiated (900 rad) 
recipients. 8or 10 days later mice were killed. The spleens from half 
the recipient mice were fixed in Bouirs and the macroscopic colonies 
counted. Spleen cell suspensions were made from the remaining mice. 
The number of cells equivalent to 3 CFU-S on day 8 and 0.75 CFU-S on 
day 10 were injected into lethally—irradiated secondary recipients. 8 
days later their spleens were fixed and the number of colonies counted. 
Self-renewal was expressed as the number of CFU-S/colony injected for 
5-10 mice per group (self-renewal index). 
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Repopulation assay 
The ability of 2 populations of stem cells to recienerate 
haematopoiesis in irradiated mice was compared directly using 
chromosome markers. The two chromosomally—distinct populations were 
injected into an irradiated recipient carrying a third marker. The 
CFU-S content of the 2 cell populations was determined from the spleen 
colony assay (see above). Recipient mice were killed at intervals and 
the mitotic populations of the bone marrow and spleen analysed. For 
analysis of the bone marrow, cells were pooled from 8 bones; femurs, 
tibias, ilias and humeru,s.Chromosome preparations were made by the 
method described by Micklem and Loutit (1966) (see below), and stained 
with 3 0/0' aceto-orscein. 50-200 mitoses were scored for each preparation. 
Chromosome spreads 
Chromosome spreads were made according to the method described by 
Micklem and Loutit (1966). 90 minutes before sacrifice mice received 
4pg/9 body weight of coichicine (Ciba) IP. Single cell suspensions of 
spleen and bone marrow cells were prepared in ice cold Hanks balanced 
salt solution. Approximately 10 cells were transferred to round bottomed 
polypropylene tubes (45mm x 4mm, 0.5ml tubes from Gelman-Hawksley) and 
centrifuged at 50g for 5 minutes. The supernatant was removed and the cells 
resuspended in 0.75% KC1 and incubated at room temperature for 8-10 
minutes. The cells were centrifuged for a further 5 minutes at 50g 
and the supernatant removed. Clark ?s fixative (3:1 absolute ethanol: 
acetic acid) was run down the sides of the tube without disturbing the 
pellet and removed immediately. This step was repeated. The cells 
were resuspended in fresh fixative and left on ice for 10 minutes, 
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centrifuged for 5 minutes at 50g and resuspended in fresh fixative. 
A drop of the fixed cell suspension was put onto the centre of a clean 
microscope slide and allowed to spread over the slide. When contraction 
of the drop began evaporation was hastened by blowing gently on the 
slide. 
Estimation of clone numbers 
The numbers of clones contributing to haematopoietic regeneration 
was estimated according to the method described by Ogden and Micklem 
(1976). Lethally—irradiated CBA mice were injected IV with 5 x 10 7 
of each of T6T6 and T6 bone marrow cells. 8 weeks later recipient mice 
were injected IP with 2 doses of HU (lmg/g body weight) or saline 7 
hours apart. 21 days later mitotic populations in the bone marrow were 
analysed and the proportion of each donor cell type calculated. Another 
group of mice received HU (or saline) at 21 day intervals and chromosome 
analysis carried out 21 days after the 4th pair of injections. The 
number of clones contributing to regeneration after haematopoietic 
depletion with HU was calculated from the binomial variance of one of 
the cell populations (Wallis et al 1975, Ogden & Micklem 1976). 
n = p(l-p)/s 2 
where n = number of proliferating clones 
p = proportion of donor 1 
1 - p = proportion of donor 2 
= variance of p 
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125 1-udR incorporation assay 
Cellular proliferation was assayed by measuring the incorporation 
of radio labelled 5-iodo-2-deoxyuridine ( 125 1-UdR: Radiochemical Centre, 
Amersham). Mice received lCi 125 1-UdR 24 hours before killing. The 
bone marrow, femurs, tibias, ilias and humerwere pooled for each 
animal and spleens were excised and fixed in 70% ethanol. Free label 
was washed out using several changes of ethanol, until the wash was free 
of radio-activity. Samples were counted on a Nuclear Enterprise gamma 
counter. The injected dose was counted and the counts/minute were 
adjusted to an injected dose of 106  counts/minute. Since the mice 
also received 
59 
 Fe in order to assay erythropoiesisadjustment was made 
for overspill from 
59 
 Feinto the 125  channel. 
59 Feincorporation assay 
Erythropoiesis was measured by uptake of 
59 
 Feinto haemoglobin. 
Mice were bled from the retro-orbital plexus into heparinised saline in 
pre-weighed polystyrene tubes 24 hours after IP injection of 0.5p.Ci of 
ferric citrate- 59 Fe. The blood was spun at 1800g for 15 minutes and 
the supernate removed. The packed cells were weighed to an accuracy 
of 0.1mg and counted on a Nuclear Enterprise gamma counter. Results 
were expressed as the percentage of injected radio-activity incorporated 
per gramme of packed erythrocytes. 
Bone marrow cultures 
Bone marrow was cultured by Dr. T. M. Dexter using the technique 
described by Dexter and Lajtha (1976). Adherent layers were formed by 
KI 
culturing 10 CBA bone marrow cells in lOmi of Fischers medium 
supplemented with 20110 horse serum (Flow Labs.) at 33 0 C or 37 °C. The 
cultures were fed at weekly intervals by removal of half the growth 
medium and addition of an equal volume of fresh medium. At the end 
of 3 weeks the adherent layers were seeded with a new inoculum of 
10 CBA bone marrow cells. At weekly intervals thereafter the cultures 
were fed as before and the non-attaching cells removed were assayed 
for stem cell function. 
The packed red cell volume was measured with a Hawksley 
microhaematocrit centrifuge and reticulocytes were enumerated by the 




It has been clearly demonstrated that haematopoietic stem 
cells from mouse bone marrow show a progressive decline in 
regenerative capacity with serial transfer (Micklem & Loutit 1966, 
Harrison 1972, Siminovitch et al 1964). The quality of stem cells 
from serially transferred bone marrow was further tested by 
comparing their capacities 
for self-renewal and 
for repopulating an irradiated host 
with those cells from normal marrow. Serially transferred stem cells 
were tested from eight weeks after transplantation, pooled cells from 
at least 3 donors being used in each experiment. 
Self Renewal 
Cells capable of forming macroscopic colonies in the spleen of 
irradiated recipients, CFU-S, were used as a direct measure of 
haematopoietic stem cell numbers (Till & McCulloch 1961). The ability 
of stem cells to self-renew was calculated from the number of colonies 
formed in the spleens of irradiated secondary recipients of primary 
colonyb.containing spleens (Till et al 1964). The results of two 
experiments are shown in Table 1.1. The concentration of CFU-S in the 
marrow of recipients of serially transplanted stem cells was not 
greatly different from that in marrow of normal mice. This was not 
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TABLE 1.1 
Numbers and self renewal of CFU-S from the bone marrow of normal mice and of irradiated recipients of normal 
or serially transferred bone marrow* 
Source of 	No. cells! 	Day of 	CFIJ 	 Self-renewal 	Ratio of self-renewal index 
bone marrow femur x 106 Assay ratio** 	index*** (transferred BM/normal BM) 
10 Recipient 	2° Recipient 
Normal 	 13.6 	 8 26.8 3.5 - 
10 22.2 18.6 - 
Transfer 1 	14.0 	 8 26,5 1.6 0.45 
10 23.4 8.8 0.47 
Transfer 3 	10.9 	 8 10.8 0,2 0.06 
10 11,2 1.1 0,06 
Normal 	 8.6 8 12.5 4.1 - 
10 12.3 15.5 - 
Transfer 1 	17.1 8 19.4 2.2 0.54 
10 19.1 9.0 0.58 
Transfer 4 	7.4 8 9.4 0.2 0.05 
10 7.1 1.3 008 
* 	Bone marrow serially transferred at 8 week intervals 
** 	No CFU-S/105 cells injected - 5-10 mice/group 
No CFU-S/colony equivalent injected - 5-10 mice/group 
surprising since Ogden and Micklern (1976) found that CFU-S numbers 
only declined after the 5th transfer. Self renewal by CFU-S 
declined progressively with transfer. CFU-S from once—transferred 
marrow self-renewed only half as well as those from normal marrow 
and those from 3 and 4 times transferred marrow only 1/20th as well 
The doubling time (TD) for CFU-S, roughly calculated from the number 
of CFU-S formed in the spleen colonies of primary irradiated recipients 
8 and 10 days after injection of bone marrow cells, was in the range 
19 - 25 hours for both normal and transferred bone marrow. 
Since CFU-S from normal and serially transplanted marrow have 
approximately the same doubling time, the overall reduction in 
self-renewal of transferred stem cells may best be explained by the 
presence in transplanted marrow of a few normally renewing CFU-S, and 
a large number of non-renewing CFU-S. It has been demonstrated that 
not all cells which form spleen colonies are capable of self-renewal 
(Till et al 1964) and it seems probably that the majority of CFU-S 
in transplanted bone marrow fail to self-renew. Those cells that do 
self-renew are evidently capable of generating large descendent clones 
since overall numbers of CFU-S do not decline until the 5th transfer 
(Ogden & Micklem 1976). An explanation that accounts for the reduced 
self-renewal of serially transplanted stem cells in terms of a small 
number of efficient CFU-S plus a large number of non-renewing CFU-S, 
is supported by the experiments of Ogden & Micklem (1976). These 
authors found that in spite of a large number of CFU-S injected at each 
transfer, the actual number of clones contributing to regeneration 
declined progressively. Transplanting bone marrow once however, failed 
to reduce the estimated number of repopulating clones. This result 
apparently conflicts with the very marked decline in self-renewal shown 
here and by Harrison et al (1978) for descendents of once transferred 
bone marrow. However where high numbers of clones are involved the 
estimate of clone numbers is likely to be inaccurate (Micklem & Ross 
1978) and it may be that self-renewal provides a more sensitive 
measure of declining stem cell numbers. 
Metcalf and Moore (1971) were able to raise the average self-
renewal of a population of CFIJ-S by killing those that were rapidly 
cycling. 	They interpreted their results as indicating an association 
between the self-renewal capacity of stem cells and their position in 
the cell cycle. In the following experiment, the results for which 
are shown in Table 1.2., the cycle active drug cytosine arabinoside 
(Ara-C), was used to determine the cycling characteristics of normal 
and transplanted CFU-S. A 10mg dose reduced the number of CFU-S in 
actively regenerating marrow, 9 days after transfer into an 
irradiated recipient, by 65%. By four weeks later, the same dose of 
Ara-C effected, if anything, an increase in marrow CFU-S. The 
majority of CFU-S in normal marrow were either in G or in very slow 
cycle. It is concluded that by the time the stem cells in transferred 
marrow were assayed they had regained the quiescent state characteristic 
of normal marrow (Becker et al 1965) and that the reduction in self-
renewal is not a result of an increased proportion of rapidly cycling 
stem cells. 
Repopulation of irradiated recipients by serially-transferred stem 
cells 
The ability of normal and transplanted stem cells to regenerate 
haematopoiesis in irradiated recipients was compared directly by the 
use of chromosome markers. Lethally-irradiated CBA mice were 
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TABLE 1.2 
The effect of a single dose of Ara-C 2 hours before killing on the 
CFU-S of normal and regenerating bone marrow (BM)* 
Source of 	 Nucleated cells! 	CFU ratio** 
bone marrow (BM) 	femur (x 106) 
Normal BM 
Saline 	 9.2 	 15.5 
10mg Ara-C 	 8.3 	 27.3 
Transfer 1 BM 
(+ 9 days) 
Saline 	 6.5 	 27.3 
10mg Ara-C 	 3.8 	 9.3 
Transfer 1 BM 
(+ 35 days) 
Saline 	 10.4 	 20.5 
10mg Ara-C 	 9.5 	 32.0 
* 	9 and R5 days after lethal irradiation and restoration with 
5 x 10 syngeneic bone marrow cells 
** No. CF1J-S/10 5 cells injected 5-10 mice/group 
21 
injected intravenously (I-V) with normal T6 bone marrow cells and either 
once transferred T6T6 or thrice transferred T6T6 bone marrow cells. 
The number of stem cells injected was determined by the spleen 
colony assay. The number of CFU-S injected was weighted in favour of 
the transferred marrow in each case. Mitotic populations in the 
recipient bone marrow were analysed at intervals. The proportion of 
mitoses derived from transferred bone marrow fell steadily to between 
10% and 25% of that predicted on the basis of CFU-S injected (Fig. 1.1). 
There was no detectable difference between once and three times 
transferred stem cells in this system. This conflicts with the 
progressive decline in CFU-S self-renewal and may reflect a 
difference between the cells that home to the spleen and those that 
proliferate in the bone marrow. Duplicate experiments using 
reversed markers gave similar results (Figs. l.la and l.lb). It is 
evident that even a single transfer of bone marrow stem cells 
profoundly affects their ability to repopulate an irradiated host. 
Circulating CFU-S in recipients of serially transferred bone marrow 
Circulating CFU-S are in the main poorly self-renewing. It has 
been suggested (Micklem et al 1975) that they may be produced as a 
result of clonal senescence and expelled from the bone marrow as waste 
products. Rosendaal (1977) has demonstrated the presence of receptors 
for anti-mouse brain antibodies on the surface of some CFU-S but not 
others, and has suggested that the presence or absence of particular 
surface structures (in this case molecules carrying the brain associ-
ated antigen) is related to the mitotic history of the cell. It is 
possible that stem cells with a poor potential for self-renewal, 















Fig. 1.1 % of total donor mitoses derived from serially-transferred bone 
marrow in the bone marrow of lethally—irradiated CBA mice reconstituted 
with normal and serially—transferred bone marrow transplanted 8-10 weeks 
previously. Each point represents a single animal. The dotted line 
represents the mitoses predicted from the number of CFIJ-S injected. 
SO-iSO mitoses scored/point. 
a 	i x 106  normal T6 cells : CFtJ-S = 230.1 x lO i x transferred 
T6T6 cells : CF!J-S = 1650. 
b 	1 x 10 normal T6T6 cells : CFtJ-S = 250 
1 x 10 1 x transferred T6 cells : CFtJ-S 2250 
C 	1 x lO normal T6 cells : CFrJ-S = 200 
1 x 107  3 x transferred T6T6 cells : CFTJ-s = 1160 
characteristics which allow them to pass easily out of the bone 
marrow into the blood. If the large proportion of poorly renewinci 
CFU-S in serially transferred marrow is due to extensive previous 
proliferation of this population, then an increased number of stem 
cells might be predicted in the circulation of these animals, The 
number of CFU-S per 106 nucleated peripheral blood cells in 
recipients of transplanted bone marrow, compared with that from 
normal animals is shown in Table 1.3, The mice were bled 10, 15 and 
22 weeks after transplantation and pooled cells from several donors 
assayed for CFU-S content, Very few CFU-S could be detected in the 
blood of recipients of transplanted marrow. There was no evidence 
that transfer number or time after transfer influenced this result. 
Since many visible spleen colonies are erythropoietic (Lewis & 
Trobaugh 1964) whether derived from bone marrow or blood, the presence 
of circulating CFU-S was further investigated by measuring red cell 
production in the spleen of recipients of peripheral blood cells 
(Table 1.3). Erythropoiesis, measured by the incorporation of radio-
labelled iron ( 59Fe) into the spleen, did not rise significantly 
above background in the spleens of mice injected with peripheral 
blood cells of irradiated repopulated donors. The lack of 
circulating CFU-S in radiation chimaeras is difficult to explain. It 
is possible that they simply have a shorter half life than 
circulating cells in intact animals and are therefore more difficult 
to detect. On the other hand, various factors have been shown to 
decrease the number of CFU-S in the peripheral blood including 
thymectomy (Petrov et al 1977) and hypercortism (Bezin et al 1975). 
In addition bone marrow sinus packing and the properties of the sinus 
wall also influence the release of cells into the circulation (Chamberlain 
et al 1975). It may be,therefore, that damage to recipient cells by 
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TABLE T.3 
Circulating CFU-S in the peripheral blood of normal mice and 
irradiated recipients of normal and serially transferred bone marro w* 
Source of 	Time after Number Nucleated Colonies/10 6 Colonies! 59 Feblood 	transfer 	of mice cells 	nucleated 	recipient uptake 
leukocytes** in weeks injeted cells 	spleen 	spleen 




Normal mice 	15 5 2.3 5.5 12.6 
Transfer 1 mice 5 4.0 0.2 0.8 
II 	3 	II 5 17 04 07 
ND 
U 	4 u 5 25 1.6 4 
5 it 5 2.6 0.5 1.3 
Transfer 1 mice 	22 5 1.3 1.3 1.7 
2 5 0.9 1.3 1.2 ND 
3 5 1.9 0.1 0.2 
1 	4 5 1.8 0.1 0 
EXPERIMENT 2 
Normal mice 	10 5 4.4 3.9 17.2 1.95±0.1 
Transfer 1 mice 5 1.8 0.3 0.5 0.340.1 
2 	If  5 1.3 0.5 0.7 0 41±0 1 
H 	4 	t 5 21 15 31 05401 
5 	I' 5 1.6 1.2 2.4 0 49±0 1 
6 5 1.3 0.8 1.0 0.300.1 
No cells 5 0 0 0 0.48±0.1 
* 	
Bone marrow serially transplanted at 8 week intervals 
** 	
Plasmagel-separated leukocytes 
0.1,.Ci 59 Fe/mouse injected 24 hours before killing 
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lethal irradiation is responsible, at least in part, for the lack of 
CFU-S in the peripheral blood of irradiated bone marrow repopulated mice. 
In conclusion radiation chimaeras, while possessing an 
increased concentration of poorly self-renewing stem cells, have very 
few circulating stem cells. This result does not, on the surface, 
support the simple notion that poor stem cells automatically tend to 
be ejected from the bone marrow into the blood stream, 
Treatment with Hydroxyurea 
The decline in stem cell function with serial transfer, reported 
here, provides further evidence for the hypothesis that haematopoietic 
stem cells, like fibroblasts in culture, have a limited growth potential 
which can be exhausted by repeated demands for proliferation. However 
in order to interpret these results merely as a normal ageing process 
accelerated, two basic assumptions need to be made, 
The process of transplantation of stem cells into an 
irradiated host will not in itself affect their growth 
potential. 
The whole stem cell population accumulates an approximately 
equal burden at each transfer. This would imply that cells are 
homogeneous with regard to their potential for self-renewal and 
are equally likely to move from G into cell cycle. 
Neither of these assumptions is well founded. Ogden and Micklem 
(1976) assumed on the basis of their calculations of the number of 
clones in transplanted bone marrow that the process of transplantation 
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did not, in itself, have any radically harmful effects, However, 
the data presented here, and elsewhere CHarrison et al 1978) 
indicates that a reduction in stem cell function occurs even after 
a single transfer. The preparation of bone marrow cell suspensions 
leads to the disruption of the haematopoietic microenvironment, 
a factor which may greatly influence stem cell behaviour (Lord et al 
1975, Schofield 1978). Radiation damage, perhaps to the bone stroma 
which is considered to be of fundamental Importance to haematopoietic 
induction and differentiation (La Pushin et al 1977, Patt & Maloney 
1972), may preclude the development of the correct haematopoietic 
environment in recipient mice. Stem cells as enumerated by the spleen 
colony assay are known to be a heterogenous population (Till et al 
1964, Metcalfe & Moore 1971). Should highly self-renewing cells be 
present in bone marrow in relatively small numbers then it is 
possible that they are diluted out during transfer. Moreover Gong 
(1978) has demonstrated that in the rat the stem cells are particularly 
concentrated in the endosteal marrow. Such cells are likely to be 
absent from conventional preparations of bone marrow cells (Gong 
1978) and thus rarely transplanted. If endosteal stem cells include 
a population of highly self-maintaining cells, absent from other 
marrow, then this might explain the reduced stem cell function in 
bone marrow repopulated mice. Finally, Rosendaal et al (1976) have 
found evidence that some stem cells are less likely to enter cell cycle 
than others: hence, individual stem cells may not necessarily 
proliferate after transplantation. 
In view of these possibilities it is important to investigate 
the effects of repeated depletion and regeneration under conditions 




function has been demonstrated in recipients of either continuous 
low dose irradiation (Schofield 1978) or repeated injections of the 
alkylating agent myleran (Hellman & Botnick 1977) both of which result 
in continual haematopoietic regeneration. These results suggest that 
even in the intact animal haematopoietic stem cells cannot proliferate 
indefinitely. However, both these agents probably impose a growing 
burden of genetic damage on the cells. 
The following experiments have been designed to investigate 
further the function of stem cells that have undergone multiple 
regeneration in situ. The daily demand for differentiated cells 
ensures that their precursors are normally proliferating rapidly. 
Drugs which destroy cells in cycle will deplete precursors while 
sparing resting or slowly cycling cells. In order to generate new 
precursor cells the normally quiescent stem cells will be induced 
to proliferate. They in turn will be killed by a further dose of 
the drug. 
Depletion of the haematopoietic system by hydroxyurea 
The cycle active drug chosen for the following experiments was 
hydroxyurea (HU) which selectively kills cells fn the DNA synthetic 
phase of the cell cycle (Phillips et al 1967). It acts by inhibiting 
the reduction of ribonucleotides to deoxyribonucleotides (Young et al 
1967). HU is rapidly cleared from the plasma; for the dose chosen 
(lmg/g body weight) the half—disappearance time is 0.80± 0.09 hours 
(Hodgson et al 1975). This ensures that the majority of cells killed 
are those in cycle at the time of injection. Hodgson found that two 
IP doses of HU 7 hours apart killed 50% of CFU-S in Balb/c mice. The 
same regime given to female CBA mice resulted in a reduction of 75% 
in CFU-S/femur and 80% in total marrow cellularity (Fig. 1.2). 
Normal levels were recovered by day 7 followed by an overshoot on 
day 10. By day 21 both femoral cellularity and CFU-S numbers were 
normal. The packed red cell volume was unaffected (Fig. 1.3) but 
blood reticulocytes after an initial decline rose to levels 3i times 
normal on day 6 returning to normal by day 10. Spleen weight 
descreased slightly during the first 24 hours but had recovered by 
day 4. 
Since the intention was repeatedly to deplete the stem cell pool by 
serial injections of HU, it was necessary to confirm that subsequent 
injectionsreduced CFU-S numbers to the same extent. Mice which had 
received 9 previous pairs of injections of HU were assayed for 
femoral CFU-S content and total cellularity after the 10th pair 
(Fig. 1.4).CFU-S were depleted by 85%. In the light of this result 
each pair of injections of HU is assumed to have depleted the stem 
cell pool by about 80%. 
The function of stem cells was measurejby their ability a) to 
self-renew in the spleen and b) to repopulate the bone marrow cavities 
of lethally irradiated mice. All KU-treated stem cells were assayed 
21 days after the last pair of injections. 
Self-Renewal 
The self-renewal of CFU-S from the bone marrow of mice which had 
received repeated injections of HU is shown in Table 1.4. It is 















HU 	- 	- 	Days 
Fig. 1.2 Total femoral cellularity ( 0 ) and femoral CFJ-S ( A ) 
at intervals after 2 i.p. injections of HU (lrrig/g body weight, 
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Days 
Fig. 1.3 Spleen weight ( E ), reticulocy-tosis ( 0 ) and packed red 
cell voliine ( i ) at intervals after 2 i.p. injections of HtJ 















H 	- 	- 	Days 
Fig. 1.4 Total femoral ceflularity ( 0 ) and femoral CFtJ-S ( 	) 
in recipients of 9 pairs of injections of HtJ (i rtlg/g body weight 
i.p. 7 hours apart at 21 day intervals) at intervals after a 
10th pair of injections. Results are expressed as % of the value 
in saline controls. 
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TABLE 1.4 
The numbers and self-renewal of CFU-S from the bone marrow of normal 
mice and of mice given pairs of injections of hydroxyurea (2HU)* 
Source of 	No. of cells! 	Day of 	CFU ratio** 	Self-renewal 
bone marrow femur x 10 	assay 	 index*** 
1 0  recipients 	20 recipients 
Normal 12.0 8 26.0 3.0 
10 21.6 20.3 
1 	x 2 HU 16.0 8 34.6 2.4 
10 23.6 18.1 
4 x 2 HU 16.5 8 31.0 1.6 
10 25.4 15.1 
Normal 9.7 8 18.5 2.3 
6 x 2 RU 12.1 8 15.6 1.3 
10 14.0 10.1 
12 x 2 RU 16.1 8 14.4 1.9 
10 16.5 9.1 
* 	2 IP injections of hydroxyurea (lmg/g body weight) or saline 7 hours 
apart, repeated at 21 day intervals. Donors killed 21 days after 
injection. 
** 	Number of CFU-S/105 cells injected - 5-10 mice/group 
Number of colonies/colony equivalent injected - 5-10 mice/group 
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consistent effect on CFU-S numbers or self-renewal. The CFU-S ID 
calculated from day 8 and day 10 data was between 16 and 22 hours 
for both normal and HU-treated CFU-S, 
In order to determine the proliferative state of normal and 
HU-treated CFU-S a single injection of HU was given IP two hours 
before sacrifice. The dose killed 75% of CFU-S in the regenerating 
marrow of mice which had been irradiated and repopulated 9 days before 
(Table 1.5). The CFU-S in normal bone marrow were found to be mainly 
in G and stem cells in RU-treated marrow had evidently regained normal 
cycling characteristics by 21 days. There was an apparent reduction 
in self-renewal of stem cells from normal mice given a single injection 
of HU. This effect was confirmed by a later experiment (page 48 	). 
Sinclair (1965) reported that HU induced a block in cultured cells 
at the border between the phase preceding DNA synthesis (C- 1 ) and ' s ' 
phase. These cells survive but are prevented for a time from 
beginning DNA-synthesis. A similar block has recently been 
demonstrated for CFU-S (Hodgson & Blackett 1977). This would lead to 
a delay in the initiation of spleen colonies resulting in small 
colonies and an apparent reduction in self-renewal. It is not clear 
why no evidence of such a block was detected in mice with a previous 
experience of HU. Possibly, previous exposure confers a resistance 
to the blocking action of the drug, but it is not clear how this could 
occur and further experiments would be needed to establish this as a 
real effect. 
Repopulation of irradiated recipients 
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The repopulating capacity of HU-treated stem cells was compared 
TABLE 1.5 
The effect of a single dose of hydroxyurea (HU) 2 hours before sacrifice 
on numbers and self-renewal of CFU-S from normal, HU treated *  and 
regenerating bone marrow (BM)** 
Treatment 	Number of 	 CFU ratio*** 	Self-renewal 
	
nucleated index**** 
cells/femur x 106 	1 ° recipients 	2° recipients 
Normal BM 
Saline 	 1.03 	 24.1 	 7.4 
HU 	 0.88 	 23.7 	 1.8 
n im nil 
Saline 	 1.22 	 30.2 	 6.1 
HU 	 0.91 	 33.7 	 5.8 
Regenerating BM 
Saline 	 6.55 	 27.3 	 ND 
HU 	 3.33 	 6.6 	 ND 
* 	2 IP injections of 	HU (lmg/g body weight) 7 hours apart, repeated 
at 21 day intervals. Donors killed 21 days after final injection. 
** 	9 days after lethal 	irradiation and restoration with 5 x 10  
syngeneic bone marrow cells. 
Number of CFU-S/10 5 cells/injected - 5-10 mice/group 
Number of CFU-S/colony equivalent injected - 5-10 mice/group 
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directly with that of normal stem cells using chromosome markers. 
Normal T6T6 bone marrow cells and bone marrow cells from CBA animals 
given 1, 4, 6, or 18 pairs of injections of HU were injected into 
lethally irradiated T6 recipients. Bone marrow mitoses were analysed 
at intervals (Fig 1.5). Little difference could bedetected between 
normal and HU-treated cells although there was an indication that 
initially normal marrow may have had a slight advantage (Fig l,Sa-d.). 
Number of clones contributing to repopulation after depletion of the 
haematopoietic system with HU 
Calculations have been made of the number of clones contributing 
to haematopoietic regeneration during serial transfer. (Ogden & 
Micklem 1976). The number declined with transfer. It was concluded 
that the collapse of the haematopoietic system, caused by serial 
transfer, was preceded by regeneration from fewer and fewer clones. 
A similar reduction in proliferating clones has been noted for fibro-
blast cultures (Holliday et al 1977). 
The following experiments were designed to estimate the number 
of clones that regenerate haematopoiesis after depletion with HU. 
Double irradiation chimaeras were produced by injecting lethally 
irradiated CBA mice with equal numbers of T6T6 and 16 bone marrow 
cells. Large numbers of cells (5 x 10 of each) were injected in an 
attempt to include any rare cell types in the inoculum. Eight weeks 
later the mice received 2 injections of HU or saline 7 hours apart. 
A similar pattern of depletion and recovery to that seen in intact 
animals was achieved by this dose of HU in radiation chimaeras (Fig L6). 
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Fig. l. 	% of total donor mitoses that are derived from Ht.T-treated 
bone marrow in the bone marrow of irradiated T6 mice reconstituted 
with marrow from normal and RU-treated mice ( pairs of injections 
at a dose of 1 mg/g body weight 7 hours apart repeated at 21 day 
intervals. Bone marrow assayed 21 days after the final pair of 
injections). Each point represents a single animal. 50-150 mitoses 
scored/point. The dotted line represents the % mitoses predicted 
from the number of CFtJ-S injected. 
a 	1 x 10 normal T6T6 cells : CFU-S = 260 
1 x 10 1 x 2HtJ CEA cells : CFCT-S = 3200 
b 	1 x lO normal T6T6 cells : CFtJ-S = 260 
1 x 10 Li. x 2HtJ CBA cells : CFU-S = 3000 
c 	1 x 10 normal T6T6 cells : CFU-S = 380 
1 x 10 6 x 2HU CEA cells : CFtJ-S = 4800 
d 	1 x 10 normal T6T6 cells: CFU-3 = 648 
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Fig. 1.6 Total femoral cellularity ( 0 ) and femoral CIFtJ-S ( A ) in 
lethally irradiatrnice repopulated with 5 x 166  bone marrow cells 
8 weeks previously at intervals after 2 i.p. injections of HTJ 
(1 mng/g body weight 7 hours apart). 	Results are expressed as 
of value in saline controls. 
and saline were repeated at 21 day intervals. Cytological exam-
ination of the bone marrow was performed 21 days after the first pair 
of injections in one experiment and after the 4th pair in a second 
experiment. The results (Fig 1.7) show the proportion of T6T6 cells 
expressed as a % of the total donor population. Each point represents 
a single animal. 100 - 200 mitoses were scored for each cell 
preparation. 
Mitoses from mice injected with saline were derived equally from 
both donor cell populations. However animals which had received 
HU showed large deviations in both directionsfrom this 1:1 ratio. 
The variance of the donor population from a 1:1 ratio can be used 
to calculate the number of repopulating clones (Micklem & Ross 1978). 
Bone marrow cells in a mouse repopulated with 1 clone only will 
obviously be of one karyotype only. Conversly if large numbers of 
clones contribute to repopulation, then the proportions of donor 1 
and donor 2 will approximate to the proportions present in the 
original inoculum; 1:1 in this case. It can therefore be seen that 
increasing fluctuations from 1:1 in the proportions of donor cell 
types indicates regeneration from fewer and fewer clones. The actual 
number of clones n can be roughly estimated from the binomial 
variance (Wallis et al 1975). Thus n = p(l-p)/S 2 where p and 1-p 
are the proportions of T6T6 and T6 cells respectively and S 2 is the 
variance of p. 
s 2 in saline injected mice was low indicating an initial 
repopulation of the irradiated recipients by a large number of clones 
(Table 1.6). Estimates of clone numbers become increasingly 
inaccurate as rt. approaches the number of mitoses scored (Micklem & 
39 
0/ 
mitoses (Dcrr T / 	 L 
Ibror 	OAJO2. 






. 	 •• • . 
00 0 0 
ME 
IEi 
Fig. 1.7 The effect of 2 doses of 2HtJ (1 mg/g body weight 7 hours 
apart repeated at 21 day intervals) on the proportions of 
2 chromosomally distinct bone marrow cell populations i the marrow 
of lethally irradiated CBA mice repopulated with 5 x 101  T6 + S x 10 
T6T6 bone marrow cells 8 weeks previously. Cytological analysis 
was carried out 21 days after the final injection of HtJ. Each point 
represents a single animal. 150-200 mitoses scored/animal. 
Experiment I : 	( 0 ) 1 x 2 HI3 
C • ) saline 
Experiment II : 	0 ) Li. x 2 HU 





Estimation of clone numbers in the bone marrow of lethally irradiated 
mice injected with 108  T6T6 and T6 marrow cells, subsequently exposed 
to hydroxyurea* nd examined cytologically 3 weeks or more later 
Treatment 	No. of 	Proportion of T6T6 mitoses** 	No. of 
mice 	 clones*** 
EXPERIMENT 1 	 Mean 	 Variance 
Saline 	 4 	0.487 	 0.0009 	 >100 
1 x 2HU 	 5 	0.564 	 0.025 	 9.8 
EXPERIMENT 2 	 Mean 	 Variance 
Saline 	 6 	0.462 	 0.0014 	 >100 
4 x 2HU 	 11 	0.459 	 0.0518 	 4.8 
* 	2 IP injections of HU (lmg/g body weight) or saline 7 hours apart, 
repeated at 21 day intervals. 1st pair of injections given 8 weeks 
after irradiation and reconstitution. 
** 	Ignoring any host mitoses 
*** 	Calculated from the mean and variance: see text 
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Ross 1978), since the latter limits the variance. Under these 
conditions it can only be inferred that the number of repopulating 
clones is equal to or greater than the number of mitoses scored. 
Regeneration of haematopoiesis after depletion with I-{U was from 
a small number of clones ( <10) both after 1 pair of injections and 
after 4 pairs of injections. It is not clear from these experiments 
whether the same repopulating clones are triggered after 4 injections 
as after 1 or whether some kind of clonal succession occurs. 
The inference from these results is that demands for haematopoietic 
regeneration in situ are met by a small number of clones capable of 
extensive proliferation. Only under the abnormal conditions of 
transplantation are many clones triggered to proliferate. In other 
words, far from heralding the collapse of the haematopoietic system 
as suggeste&by serial transfer (Ogden & Micklem 1976) 	Oligoclonal 
regeneration may be the normal state of affairs. It is, however, 
possible that the observed ol igoclonal regeneration in HU treated 
mice, may be due to the relatively small initial depletion; 80% as 
against almost 100% in irradiated repopulated mice. The system 
used here is still essentially an artificial one, since the double 
chimaeras are initially established by irradiation and repopulation. 
However, it is likely to reflect what happens in intact animals better 
than serial transfer. 
The lifespan of fibroblasts in culture has been expressed in terms 
of the number of population doublings of which the cells are capable. 
For human foetal lung fibroblasts this is about 50 (Hayflick 1965). 
Similar calculations based on regeneration during serial transfer have 
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estimated the mitotic lifespan of haematopoietic stem cells as 80 - 
200 cell divisions (Ogden & Micklein 1976). It is evident , however, 
that if clonal succession does operate then such calculations are 
meaningless. Individual cells may possess a limited lifespan based 
on mitotic experience but it is clear that simplistic calculations 
based on regeneration in transplanted cell populations are probably 
not very useful. 
Effect of a regime of 5 injections of hydroxyurea on the 
haematopoietic stem cells 
Rosendaal et al (1976) have described a regime of 5 injections of 
H1J over a period of 30 hours (5HU) that depletes the marrow CFU-S by 
approximately 97%. The surviving CFU-S, presumed to have remained 
in G and G1  throughout this period and therefore to have been 
resistant to stimulating factors which induced the remainder into cell 
cycle, were found to have a very high self-renewal capacity. This 
suggested that the stem cells which are most likely to proliferate 
on demand are those which have the highest probability of differentiation. 
The following experiments were designed to 
Investigate further the nature of these '5HU-resistant' 
stem cells, and 
determine the effect on the haematopoietic system of 
repeated applications of this regime. 
Mice received 5 IP injections of RU (lmg/lg B.Wt.) at 0,-5.,-8, 
-24 and-30 hours (5HU). Two hours later femoral CFU-S and cellularity 
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had been reduced by 99% and 77% respectively. The self-renewal 
of the surviving 1% of CFU-S was approximately 4 times higher than 
normal (Table 1.7). Femoral cellularity and numbers and self-
renewal of CFU-S had returned to normal when assayed 21 days later. 
A second exposure to 5HU 8 weeks after the first reduced femoral 
cellularity by 84% and CFU-S by 96% (Table 1.8). The self-renewal 
of the surviving CFU-S was again greater than normal. It is evident 
that recovery of the stem cell pool from 1% of normal, did not 
deplete the marrow of highly self-renewing, obstinately non-cycling 
CFU-S. One possible explanation is that only a few of the 'good' 
stem cells are induced to proliferate at a time. This would 
result in 
oligoclonal regeneration of the type demonstrated in 
mice given 2HU, and 
leave a reservoir of 'good' stem cells not easily depleted 
by repeated haematopoietic regeneration. 
Between 2 and 24 hours after the fifth injection of HU the total 
femoral cellularity was reduced by a further 20% (Table 1.9). CFU-S 
however had doubled in number during this time. The TD of CFU-S 
from both'5 HU-treated'and normal marrow (calculated from day 8 and day 
10 data) was in the range of 19-25 hours. 
Since the CFU-S in a non-cycling state may possess a greater 
capacity for self-renewal than those in a cycle (Metcalfe & Moore 1971) 
it is conceivable that '5 HU-resistant' CFU-S renew well purely on 
account of their quiescent state. However, 24 hours after the final 
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TABLE 1.7 
The numbers and self-renewal of CFU-S from the bone marrow of normal 
mice and of mice given a regime of 5 injections of hydroxyurea (5HU)* 
Source of 	Number of 	Day of CFU 	Self-renewal Ratio of SR 
bone marrow 	cells/femur assay 	ratio** i n dex*** 	index (5HU BM/ 
x 106 	 normal BM) 
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Normal 
2 hrs. after 
1 x 5HU 
Normal 
10 days after 
1 x 5HU 
Normal 
21 days after 
1 x 5HU 
9.5 8 24.0 2.6 - 
10 22.0 8.7 - 
1.7 8 1.1 8.4 3.2 
10 2.0 36.3 4.1 
8.5 8 16.2 1.6 - 
8.3 8 18.0 3.4 2.1 
11.6 8 19.6 5.0 - 
10 18.4 23.9 - 
10.5 8 13.0 3.5 0.7 
* 	5 IP injections of hydroxyurea (lmg/g body weight) or saline at 
0,-5,-8,-24 and-30 hours. 
** 	Number of CFU-S/10 5 cells injected - 5-10 mice/group 
*** Number of colonies/colony equivalent injected - 5-10 mice/group 
TABLE 1.8 
The number and self-renewal of CFU-S in the recipients of bone marrow 
from normal mice and mice given 2 regimes of 5 injections of h yd roxyu rea* 
Source of 	Number of 	Day of Number of CFU ratio** Self-renewal 
bone marrow 	cells/femur assay 	CFU/femur 	 index*** 
0/ 	 0I 
of normal 	 of normal 10  recipients  20  recipients 
Normal 	 100 	8 	100 	 9.7 	3.1 
2 hours after 	16 	8 	4 	 2.9 	8.4 
2 x 5HU 
* 	Recipients of 2 regimes of 5 injections of HU (lmg/g body weight)IP 
at 0,5,-8.-24 and-30 hours 8 weeks apart. 
** 	Number of CFUJ105 cells injected - 5-10 mice/group 
*** Number of CFU/colony equivalent injected - 5-10 mice/group 
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TABLE 1.9 
The numbers and self-renewal of cycling and non-cycling CFU-S in the 
bone marrow of normal mice and mice given a regime of 5 injections of 
hydroxyurea (5HU)* 
Source of 	 No. of 	Day of CFU 	Self- 	Ratio of 
bone marrow 	cells/femur assay 	ratio*** renewal self-renewal 
x 106 	 index****ind ex  (5HU BM/ 
normal BM) 
Normal 	 12.6 8 16.2 1.6 - 
10 13.4 6.6 - 
2 hours after 	 3.6 8 1.6 6.5 4.0 
5 HU 10 2.1 28.9 4.4 
24 hours after 	1.3 8 7.4 8.9 5.6 
5 HU 10 7.5 40.0 6.0 
24 hours after 5HU 	1.3 8 3.1 5.6 3.5 
(non-cycling cells)** 10 4.5 31.3 4.7 
10 days after 5HU 	8.3 8 18.0 3.4 2.1 
10 days after 5HU 	8.4 8 18.0 3.3 2.0 
(non-cycling cells) 
* 	5 IP injections of.hydroxyurea (lmg/g body weight) or saline at 
0,-5,--8,-24 and-30 hours. 
** 	A single injection of hydroxyurea (lmg/g body weight) 2 hours 
before killing 
Number of CFU-S/10 5 cells injected - 5-10 mice/group 
Number of CELl-S/colony equivalent injected - 5-10 mice/group 
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injection , 5HLI-resistant CFU-S self-renewed approximately 5 times 
better than normal (Table 1.9). Since 50% of these cells are 
susceptible to killing by a further injection of HU they are evidently 
a rapidly proliferating population. Thus, the enhanced capacity 
for self-renewal in '5HU-resistant' stem cells was at most marginally 
affected by their proliferative state. If anything CFU-S in cycle 
during the 2 hours before sacrifice of donors, self-renewed better 
than those in G0 , since their removal by HU reduced the overall self-
renewal rate. It seems therefore that rapid cell cycle is related to 
poor self-renewal not as cause and effect, but in a looser way: the 
obverse of the finding that potent stem cells are barely in cycle would 
be that impotent stem cells are frequently in cycle, and an association 
has previously been noted between poor self-renewal and a high frequency 
of cells in S-phase (Gidali et al 1974, Micklem et al 1975). 
By day 10 1 5HU-resistant CFU-S were no longer susceptible to a 
further dose of HU and had apparently regained the G 0 state 
characteristic of normal cells (Table 1.9). CFU-S from normal 
recipients of 1 dose of HU 2 hours before sacrifice showed reduced 
self renewal confirming similar results described earlier (page 34 ) 
Again, no reduction in self - renewal was seen in CFU-S from animals 
with a previous experience of HU. 
Repopulation of irradiated recipients 
The regeneration of haematopoiesis in irradiated recipient mice 
by stem cells from normal and 5HU-treated donors was compared using 
chromosome markers as previously described (Fig. 1-8). Figures 1.8a 
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Fig. 1.8 % of total donor mitoses that are derived from RU-treated bone 
marrow in the marrow and spleen of lethally irradiated mice repopulated with 
bone marrow cells from normal and 5 RU-treated mice (S i.p. injections of 
RU at a dose of 1 ing/g body weight at 0,-5,-8,-24 and-30 hours repeated 
at 8 week intervals). Each point represents a single animal. SO-iSo 
mitoses scored/animal. The dotted line represents the % mitoses 
predicted from the CFtJ-S injected. 
( 0 ) bone marrow; ( S ) spleen 
a 	Recipients : CRA 6 Donors 	: 2 x 106  normal T6 cells : CFtJ-S = 453 
2 x 10 1 x SH[J T6T6 cells : CFU-S = 72 
Mice killed 2 his, after SHU 
b 	Recipients : CBA 
6 Donors 	: 1 x 106  normal T6T6 cells : CFU-S = 220 
:SxlO 1x5HUT6 cells: CFU-S=l00 
Mice killed 2 his, after SHTJ 
c 	Recipients : OBA 6 
Donors 	: 4 x 106  normal T6 cells : CFtJ-S = 780 
2 x 10 1 x SHtJ T6T6 cells : CFtJ-S = 528 
Mice killed 21 days after SHrJ 
d 	Recipients : T6 	6 Donors 	: 2 x 106  normal T6T6 cells : CFU-S = 544
2x10 3x5HU CBA cells: CJ-8LU 
Mice killed 2 hours after 3 x SHU 
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and 1.8b show the results of two experiments in which bone marrow 
cells had been prepared 2 hours after the final injection of HIJ. 
The donor populations carried reciprocal markers in each case. The 
number of CFU-S injected was weighted 6 times in favour of normal 
marrow in Fig 1.8a and 2 times in Fig 1.8b. The proportion of 
'5HU-mitoses' in the bone marrow reached 3-4 times the predicted 
value within the first 8 days of the experiment. The proportion 
in the spleen was slightly lower. 5HU-treated stem cells tested 21 
days after the final injection (Fig 1.8c) at a time when number and 
self-renewal of CFU-S had returned to normal (Table 1.7), slowly 
outgrew normal stem cells to give two times the'expected' number of 
mitoses. 
Bone marrow cells from donors subjected to 3 series of 5 doses 
of HU at 8 week intervals (3 x 5HU) were tested for repopulating 
potential in a repeat of the experiment described above. The number 
of CFU-S injected was weighted 12 times in favour of the normal 
cells. The proportion of '3 x 5HU-mitoses' was 12 times higher than 
the 7.4% predicted (Fig. 1.8d). This result confirmed the self- 
renewal data which suggested that repeated regeneration from the small 
number of stem cells surviving 5HU did not adversley affect their function. 
The speed at which 5HU—treated stem cells outgrew normal stem 
cells was somewhat surprising in view of the spleen colony data. By 
day 8, the proportion of '5HU-mitoses' was 3-4 times that predicted, 
but '5HU-spleen colonies', at the same time, were not apparently 
3-4 times larger than normal. The rapidity of the increase in numbers 
of '5HU-mitoses' suggested that treated stem cells may have a faster 
doubling time than normal cells. However, CFU-S surviving 1 x 5HU had 
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approximately the same doubling time as normal CFU-S (Table 1.7). 
One drawback of techniques that involve chromosome markers is 
that only cells in mitosis are scored. Non-dividing differentiated 
cells e.g. erythrocytes are not scored. The relatively low self- 
renewal of normal CFU-S as compared with '5HU-resistant' CFU-S suggests 
that a greater proportion of normal stem cells form differentiating 
progeny. Assuming an equal number of mitoses between stem cells and 
end cells, then the latter would be formed more rapidly by the progeny 
of normal stem cells. End cells would not, of course, be pickedupin 
assays of mitotic cells, and they would be expected to emigrate from 
spleen colonies. Thus estimates of the size of descendent clones, 
during repopulation of an irradiated host, would tend to be weighted 
in favour of 'SHU-resistant' stem cells. 
The following experiments were designed to investigate the extent 
to which normal and '5HU-treated' bone marrow stem cells differentiate 
rather than proliferate. The prediction would be that normal stem 
cells would tend to produce functional end cells such as erythrocytes 
sooner than '5HU-resistant' stem cells. By radiolabelling DNA and 
haemoglobin with 125i  and 59Fe respectively it was possible to compare 
cellular proliferation and erythropoiesis in irradiated recipients of 
normal and '5HU-resistant' stem cells. Lethally irradiated mice were 
injected with either 106  bone marrow cells from mice given 5 
injections of saline or lO cells from '5HU-treated' mice. Cell 
suspensions were prepared 2 hours after the final injection. These cell 
doses were chosen from previous data (Table 1.7) as being likely to 
ensure the injection of similar numbers of CFU-S. A control group 
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received no bone marrow cells. When the donor marrow suspensions 
were assayed for CFU-S content however, the calculated number of 
normal CFU-S injected per recipient proved to be 108 as against 40 
'5HU-resistant'CFIJ-S. 
The data of Hasthorpe and Hodgson (1977) suggests that neither 
erythropoietin sensitive cells nor colony forming cells in agar 
(CFU-C), both of which were sensitive to HU, contribute detectably 
to haematopoietic recovery after transplantation into lethally-
irradiated mice. It is assumed for the purpose of these experiments 
that the proliferating haematopoietic cells observed in the femur and 
spleen of marrow reconstituted irradiated mice are derived 
predominantly from injected CFU-S. 
Figure 1.9 shows the manufacture of new erythrocytes, measured by 
59 Feincorporation in peripheral blood from 4 days after irradiation 
and reconstitution. The results are expressed as the % of the 
injected dose incorporated in lg of packed red cells. In recipients 
of normal marrow the synthesis of new erythrocytes rose from 
background levels on day 4 to a peak on day 8. There was a lag of 
about 48 hours in recipients of '5HU-treated' bone marrow. This seems 
to indicate that normal stem cells are more likely to differentiate 
than '5HU-treated' stem cells. However, the number of normal CFU-S 
injected proved to be 108 as against 40 '5HU-resistant' CFU-S. These 
results therefore are difficult to interpret and may merely be a 
consequence of the CFU-S dose. The higher incorporation of 59  Feinto 
the spleens of recipients of normal marrow (Fig 1.10) was probably 
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Fig. 1.9 59  Fe incorporation into peripheral blood erythrocytes at 
in.ervals after repopulation of lethally irradiated mice with either 
100  bone marrow cells from normal mice 
( 
L ) or 10 bone marrow cells 
from SHtJ-treated mice (0 ). 	5 i.p. injections of HtI (lnig/g body 
weight) at 0, 5, 8, 24 and 30 hrs. Bone marrow suspension prepared 4. 
at 32 hrs. Results are expressed as the mean % injected dose - S 0 E 0 /g 
packed red cells for groups of 3 mice. 	CFU-S injected : Normal = 
108; SHtJ = 40. 	The shaded area represents the mean for iminjected 
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Fig. 1.10 	Fe incorporation into the spleen of lethally 
ir'adiated mice at intervals after repopulation with either 
10 bone marrow cells from normal mice () or 107 bone 
marrow cells from SHtJ-treated mice (0)• S i.p. injections 
of Htl (lmg/g body weight) at 0, 5, 8, 24 and 30 hours. Bone 
marrow suspensions prepared t 32 hours. Results are expressed 
as the mean % injected dose - S.E. for groups of 3 mice. 
CFIJ-s injected: Normal= 108; 5HtJ= 140. The shaded area represents 
the mean for uriinjected controls 95% confidence limits. 
Cellular proliferation in the bone marrow and spleen was measured by 
125 IUdR uptake. The 125 1-UdR incorporation in the bone marrow 
(Fig l.11a) and spleen (Fig l.11b) of recipients of 5HU-treated bone 
marrow was l-2 times higher than in recipients of normal marrow in 
spite of a 2J fold deficit in the number of CFU-S injected. This is 
the result that would be predicted from self-renewal (Table 1.7) 
and repopulation (Fig 1.8) data. Mitotic activity reached a peak on 
days 8 and 9 in the bone marrow and 9 and 10 in the spleen. 
These experiments demonstrated the presence in the bone marrow 
of a population of stem cells capable of extensive self-renewal which 
are resistant to repeated exposure to HU. and presumably difficult to 
trigger into mitosis. They appear to overtake normal cells rapidly 
in repopulation experiments possibly due to a delay in the production 
of non-dividing end cells, although no conclusive proof of this has 
been found. They are evidently able to generate large descendent 
clones since they maintain their advantage over normal cells for 
considerable periods. Experiments reported here (Table 1.6) suggest 
that haematopoietic regeneration after depletion with HU might be 
obliclonal 
Regeneration of haeniatopoiesis from cultured bone marrow stem cells 
The recent development of a system whereby haematopoietic stem 
cells can be maintained in culture (Dexter & Lajtha 1976) has enabled 
haematopoietic differentiation to be studied in vitro. Initially, 
when bone marrow cells are cultured under appropriate conditions, 
an adherent layer is formed in the culture bottles, composed mainly of 





























Fi.1.11 '125 I-UdR incorporation into the bone marrg (l.11a) or spleen (1.11b) of 
lethally irradiatd mice repopulated with either 10 bone marrow cells from normal 
mice ( 	) or 10' bone marrow cells from IHJ-treated mice ( • ). 5 i.p. injections of IIU (ling/g body weight) at 0, 5, 8, 24 and 30 hours. The results are expressed as 
the mean 1og10/adjusted counts/min.± S.E. for groups of 3 mice. The shaded area 
represents the mean for uninjected controls t 9% confidence limits. 
Ui 
c-h 
(Allen & Dexter 1976). The adherent layer apparently provides the 
microenvironment necessary for haematopoiesis since tnoculation of 
the cultures with fresh bone marrow cells results in the proliferation 
and differentiation of haeniatopoietic stem cells for several weeks. 
Furthermore congenital lesions of the haematopoietic microenvironment 
in vivo are associated with the inability of adherent layers established 
from such donors to maintain haematopoiesis in vitro (Dexter & Moore 
1977). Following removal of all non-adherent cells from the cultures, 
CFU-S numbers recover by the following week and are maintained at a 
high level for the duration of the culture (Dexter et al 1977a). 
Presumably the non-adherent CFU-S are derived from those stem cells 
detected within the adherent layer (Dexter et al 1977a). Following 
refeeding, by replacement of half the growth medium by fresh medium, 
the adherent and non-adherent cells go into rapid cycle (Dexter et al 
1977a). It appears that the process of refeeding stimulates a 
repopulation mechanism in which the depletion of non-adherent cells leads 
to the self- renewal and differentiation of adherent CFU-S. It seemed 
therefore that this system might provide an alternative method of 
studying the effects of repeated proliferation on stem cell function. 
The following experiments, done in collaboration with Dr. T. M. Dexter, 
were designed to investigate the regenerative potential of stem cells 
maintained in culture for several weeks. 
CBA bone marrow cells were used both for the adherent layer and 
the subsequent inoculum. The cultures were maintained at 33° C and 
37° C and fed once a week. Total non-adherent cell numbers per culture 
for both temperatures remained fairly constant for up to 8 weeks 
(Fig 1.12) indicating approximately one population doubling per week. 
CFIJ-S were detectable in fairly large numbers (Fig 1.12) until 4 weeks 
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Fig. 1.12 Total cellularity ( 
of CFtJ-s ( A 6 A ) per culture 
cultured at 33 C (open symbols) 
0 , • ) and number 
in bone marrow 
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but had practically disappeared by 6 weeks. Moore and Dexter (1978) 
have described strain differencesfor the length of time for which 
haematopoisis can be maintained in vitro. Syngeneic co-cultures 
of CBA bone marrow apparently regress particularly fast. As well as 
proliferation of CF1J-S, bone marrow cultures also support the 
production of granulocytes and their precursors, megakarocytes 
and their precursors and erythroid precursors (Dexter et al 1977b, 
Testa & Dexter 1977, Williams et al 1978). The cultures described 
here showed the initial extensive granulopoiesis and accumulation 
of blast cells reported previously by Dexter et al (1977b). 
Granulocyte numbers declined with time in culture. 
Non-adherent cultured T6T6 cells were injected into lethally irradiated 
CBA mice along with normal 16 bone marrow cells. Mitotic populations 
in recipient bone marrow and spleen were analysed at intervals. The 
results for cells maintained in culture for one week at 33 ° C and 37°C 
are shown in Fig 1.13. The numbers of CFU-S injected were weighted 
4-6 fold in favour of the cultured cells. The contribution of 
cultured cells to the donor mitotic population on day 7 was only about 
50% of that predicted. This declined-to about 10% by day 40. No 
difference was observed between 33°C and 37 ° C cultures in spite of 
evidence that 33 ° C cultures result in more prolific growth of 
adherent lyears and a better CFU-S renewal (Dexter et al 1977b). 
Stem cells cultured for 4 and 7 weeksshowed a further progressive 
decline in regenerative potential (Figs 1.14 and 1.15a). 
It is clear from these results that, like serial transplantation, 
the growth of bone marrow cells in culture affects their ability to 
















10 	20 	30 	40 
Days 
Fig. 1.13 % of total donor mitoses derived from cultured 
bone marrow cells in the spleen ( • ) and bone marrow ( 0 ) 
of lethally irradiated CBA mice repopulated with normal T6T6 
bone marrow cells and T6 bone marrow cells cultured for 1 week 
at a 33 
0 C and b 37 0  C. The dotted line represents the 4 mitoses 
predicted from the CFtJ-s injected. Each point represents a 
single animal. SO- 150 mitoses scored/animal. 
a. 5 x 10 normal cells: CFU-s = 15 
x 10' cultured cells: CFtI-s = 101 
b 5 x lO normal cells: CFtJ-s = 15 
2.4 x 10 cultured cells: CFrJ-s = 60 







10 	 20 
Days 
Fig. 1.14 % of total donor mitoses derived from cultured bone 
marrow in the spleen ( • ) and bone marrow ( 0 ) of lethally 
irradiated CBA mice repopulated with normal T6T6 bone 0marrow cells 
and T6 bone marrow cells cultured for L. weeks at a 33'C and 
b 37 °C. The dotted line represents the % mitoses predicted from 
the Cfl1-s injected. Each point represents a single animal. 
O- lO mitoses scored/animal. 
5 x lO normal cells: CFtJ-s = 8 
5.6 x 10' cultured cells: CFtJ-s = 28 
5 x lO normal cells: CFTJ-s = 8 
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Days 
Fig. l.l 	% of total donor mitoses derived from cultured bone 
marrow in the spleen ( • ) and the bone marrow ( 0 ) of lethally 
irradiated CBA mice repopulated with normal T6T6 bone marrow cells 
and T6 bone marrow cells cultured for 7 weeks at 37 C. The 
dotted line represents the % mitoses predicted from the CFtT-s 
injected. Each point represents a single animal. 50- 150 mitoses 
scored/animal. 
5 x lO normal cells : CFU-s = 8.0 
x 10 cultured cells : 	CFtJ-s = 5,8 
5 x lO normal cells : CFtJ-s = 20.5 
5 x 10 cultured cells : 	(IFU-s = 5.0 
regenerative ability after only 1 week in culture suggests that this 
is not due solely to an increase in the mitotic burden of the stem 
cells. The limitations of a system that involves the removal of 
haenatopoietic stem cells from their normal milieu, with 
accompanying loss of rare cells and destruction of the microenviron-
ment, have already been discussed with reference to the serial 
transfer experiments. In addition, since only cells from the 
culture supernatent were assayed it is conceivable that these 
experiments selected for a sub-population of cells which represent 
the poorly proliferating progeny of more'potent' stem cells situated 
within the adherent layer . One experiment, however, gave a totally 
discordant result. Figure 15b shows the results of a second experi-
ment using 7 week cultured cells. Within the first 10 days 
cultured stem cells generated numbers of mitoses 3 times greater 
than that predicted in the bone marrow and li times greater in the 
spleen. By day 22 'culture-derived' mitoses had dropped to the level 
seen previously for 7 week cultures (Fig 1.15a). The inclusion of a 
very rare 'powerful' stem cell in the cultured cell suspension might 
give a result of this sort. Alternatively, since in vitro 
transformation has been observed in allogenic CBA/BDF 1 co-cultures 
and in syngeneic CBA co-cultures of bone marrow and foetal liver 
(Moore & Dexter 1978) - this result could have been the result of 
transformation of the cultured stem cells. However, as mice from 
this experiment, kept for 18 months, failed to develop leukaemia, 
this possibility could not be substantiated. 
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nrcriiccrn 
Human diploid fibroblasts cultures have a finite lifespan 
that can be measured in terms of population doublings (Hayflick 1965). 
That cell populations in vivo also possess limited powers of self 
replication has been suggested by serial transplantation experiments 
(Siminovitch et al 1964, Micklein & Loutit 1966, Harrison 1972). 
The lifespan of haematopoietic stern cells has been estimated, on 
certain assumptions, as between 80 and 200 mitotic divisions (Ogden 
& Micklem 1976). However, it has not been clear whether such 
experiments are representative of events in the intact animal, since 
considerable disruption of the normal environment is inevitable. 
The expericents described here attempted to clarify this point. 
Serial transplantation versus hydroxyurea 
Haernatopoietic regeneration following serial transplantation of 
bone marrow resulted in a reduction in the capacity of regenerated 
haematopoietic cells to function as stem cells. These results lent 
weight to previous data which had suggested a finite lifespan for 
haematopoie-tjc stem cells in vivo. However, it is also evident that 
even a single transfer effected a substantial reduction in stem cell 
function. In particular, the failure of subsequent transfers to 
decrease further the repopulating ability of the stem cells (Fig 1.1) 
suggested that the process of transplantation was in itself harmful 
to stem cells in a way that had little to do with an increased 
mitotic history. This view was supported by the repopulation 
experiments with stem cells maintained in vitro. After only one 
week in culture (equivalent to approximately one CFU-S population 
64 
doubling) cultured stem cells were unable to compete successfully 
with normal stem cells. 
We could find no evidence that stem cell population induced 
to proliferate repeatedly in situ, were subject to a 'Hayflick' limit. 
Repeated haematopoietic depletion induced by serial injections of HU 
showed that the stem cell pool, in situ, was capable of very 
extensive proliferation without any noticeable reduction in steir cell 
function. This result contrasts with the permanent reduction in 
CFU-S renewal described in animals treated either with 4 x 450 rad of 
X-rays at 21 day intervals (Hendry et al 1974) or with serial 
injections of the alkylating agent myleran (Morley & Blake 1974, 
Wu & Lajt}-a 1975, Schofield 1978). However, since there is 	evidence 
that both treatments damage non-cycling cells (Delmonte 1978a, 
Dexter et al 1978) as well as causing lesions of the haematopoietic 
microenvironment (Morley et al 1975, Delmonte 1978b, Dexter et al 
1978) it is not possible to explain results obtained with X-rays 
or alkylating agents simply in terms of exhaustion of the stem cell pool. 
While HU is apparently cytotoxic only for cycling cells (Phillips 
et al 1967) it would be useful to determine its effect, if any, on 
the haematopoietic microenvironment, preferably using Dexter's in vitro 
system (Dexter & Lajtha 1976). 
Microenvironment versus stem cell loss 
The preparation of bone marrow stem cell suspensions and the 
subsequent inoculation of irradiated animals or culture monolayers 
with a small number of cells resulin (a) the disruption of the 
haematopoieti c 
65 
microenvironment and (b) the possible loss of rare cell types. 
The fundamental importance of the haematopoietic microenvironment 
to stem cell function has been suggested by several authors (Lord et 
al 1975, Cairns 1975, Dexter & Moore 1977). Indeed, Schofield (1978) 
has proposed that the occupation of specific haematopoietic 'niches' 
may confer on some stem cells properties of indefinite self-renewal. 
There is evidence both in vivo and in vitro to suggest that it may not 
be possible to recreate a normal haematopoietic microenvironment 
in an irradiated host. Maloney & Patt (1972) have described prolonged 
hypoplasia of locally irradiated bone marrow given 1000 rad and 
Dexter et al (1978) have shown that bone marrow from recipients of 
repeated low-dose irradiation provides a defective microenvironment 
for the in vitro proliferation of CFU-S. In addition, there is some 
evidence that thymus-dependent lymphocytes, a population of cells known 
to recover very slowly after irradiation and reconstitution (Rozing 
et al 1977) may play a role in haematopoietic regulation (Lord & 
Schofield 1973, Burek et al 1977, [iktor-Jedrzejczak et al 1977, 
Goodman 1978). Likewise, it is probable that adherent monolayers 
in bone marrow cultures also fail to recreate a completely normal 
haematopoietic milieu. This may be particularly true of CBA 
syngeneic co-cultures (Moore & Dexter 1978). 
As well as the probable loss of a suitable microenvironment 
for normal haematopoietic activity it may be that rare but 
'powerful' stem cells are not represented in the relatively small 
numbers of cells used in serial transplantation (5 x 106)  or to 
inoculate the adherent layer in bone marrow cultures (1 x 	Even 
assuming that such cells are included in the initial cell inoculum 
subsequent transfers would dilute them out. That less frequent, 
more powerful, stem cells were being lost by dilution was suggested 
by the self-renewal data shown in table 1.1. The overall decrease 
in self-renewal with transfer was probably attributable to 
progressively diminishing number of self-renewing CFU-S associated 
with increasing proportions of non-renewing CFU-S. 
It is possible that the weekly replacement of half the culture 
supernatent with fresh medium could result in a similar dilution 
effect. However this would imply that the 'good' stem cells were in 
the supernatent. Dexter et al (1977a) however have shown that 
supernatent CFU-S are most probably descended from those CFU-S 
detected within the adherent layer. If the latter represent a more 
powerful population of stem cells (possibly by virtue of their position 
within the monolayer microenvironment) then it may be that by 
assaying only those stem cells in the supernatent a population of poorly 
renewing descendents 	selected for. 
Immortality versus oligoclonal regeneration 
The failure of repeated injections of HU to exhaust the 
haematopoietic stem cell pool suggests the existence of cells with 
very extensive, possibly unlimited, powers of self-renewal. Stem 
cells with unlimited proliferative potential ('immortal' stem cells) 
have been proposed for several renewing systems: haematopoiesis 
(Schofield 1978), skin (Cairns 1975), and fibroblasts (Kirkwood & 
Holliday 1975). An immortal stem cell is one whose probability of 
self-renewal (p) equals unity and which gives rise to at least one 
daughter cell with p = 1. If however each demand for haematopoietic 
regeneration is met by a few cells capable of generating large 
descendent clones then the pool of the most powerful, stem cells could 
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be for practical purposes inexhaustible without necessarily being 
immortal. The evidence described here suggested that, contrary to 
the multiclonal regeneration following irradiation and bone 
marrow reconstitution (Ogden & Micklem 1976), in situ haernatopoietic 
regeneration, at least in established radiation chimaeras 	(and by 
implication in normal mice) may well be met by the sequential trigger-
ing of a few cells at a time. 
It has been proposed by a number of authors (Wegniann & Gilman 1970, 
Minz & Palm 1969, Nesbitt 1971).that during embryongenesis the 
haematopoietic stem cell pool is derived from a small number of 
primordial cells. However, inihe absence of sequential studies, 
an alternative explanation of the data - that few clones were active 
at the time of assay - is equally tenable (McLaren 1972, Lewis et al 
1972). One sti.Jy by Stone et al (1964) involving two serial bleeds 
of chimaeric cattle twins, did demonstrate an apparently random 
variation in erythrocyte ratios, implying that oligoclonality is a 
feature of normal haematopoiesis. 
Since the technique used here involved killing the mice it is 
not clear whether clonal succession occurred in KU-depleted chimaeras. 
Serial studies using other experimental systems, such as heterozygotes 
for X-linked variants of the enzyme phosphoglycerolkinase (Nielson & 
Chapman 1977) and fusion chimaeras between 'beige' (Murphy et al 1973) 
and normal mice, should lead to a much better understanding of the clonal 
make-up of the haematopoietic system. 
Clonal succession, however, does not necessarily preclude a pool 
of ininortal stem cells. Data presented here and elsewhere (Rosendaal 
et al 1976) suggest that the most powerful stem cells are also the most 
cycle-refractory. Immortal cells are 
very resistant to mitogenic stiurnulus 
rarely. In practice, it is difficult 
system between 'immortal' and 'mortal 
succession based on the latter allows 
haematopoietic regeneration. 
likely, therefore, to be 
and thus be activated but 
to differentiate in this 
stem cells, since clonal 
for almost unlimited 
A potential disadvantage of an immortal stem cell would be that 
any transcriptional errors accuninulated in the DNA during mitoses 
would be retained permanently by the haematopoietic system. However, 
Cairns (1975) has suggested that one way of preventing this would be 
by conservative replication of the DNA, whereby one daughter cell 
which would remain fixed in an 'immortal' cell 'niche' would retain 
both parental strands of DNA. 
Whether the most powerful stem cells are immortal or merely 
activated sequentially only quite a small pool need be postulated 
to account for the apparently limitless proliferative potential of 
haematopoietic stem cells in situ. Rare cells, as mentioned 
previously, would be easily lost during serial transfer or in the 
initiation of bone marrow cultures. 
We conclude that the apparently finite life span of serially 
transplanted and cultured stem cells is very probably an artifact 




The results described in Chapter I demonstrated a decreased 
ability of serially transferred haematopoietic stem cells both to 
self-renew and to repopulate irradiated mice. A loss of proliferative 
potential in the pluripotent stem cell population might be expected 
to result in a failure of differentiated progeny to function normally. 
However, Ogden and Micklem (1976) have shown that apparently normal 
erythropoisis is maintained for at least 5 transfers. The 
experiments described in this chapter were designed to investigate 
the ability of lymphoid cells descended from serially transplanted 
haematopoietic stem cells to mount a normal immune response. 
Extensive data suggest that lymphocytes are derived from 
pluripotent haematopoietic stem cells (Barnes et al 1959, Micklem et 
al 1966, Trentin et al 1967, Wu et al 1968, Nowell etal 1970, Edwards 
et al 1970). While it has not been possible to demonstrate lymphoid 
spleen colonies, evidence exists for a close relationship between CFU-S 
and lymphoid cells (Trentin et al 1967, Wu et al 1968, Abrahamson et 
al 1977) 
Lymphocytes can be divided initially into 2 main categories; those 
which are dependent on the thymus for differentiation and maturation 
(T cells) and those which are not (B cells). T and B cells can be 
functionally distinguished since broadly speaking 
) B cells are respons- 
ible for antibody production and T cells for cell-mediated immune 
reactions. In addition, I cells play an important regulatory role 
helping (Waldmann 1977) or suppressing (Gershon 1974) responses of 
other cells. In addition, lymphocytes can be subdivided on the basis 
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of surface antigens and receptors. 
T cells express 4 main alloantigens on their surfaces: Thy. 1 
and Ly. 1, 2, and 3. Thy. 1 alloantigen is expressed by all T cells 
in varying concentrations while unique combinations of Ly. 1, 2 and 
3 are expressed by distinct I cells subsets. The combinations of Ly. 
alloantigensexpressed,either Ly. 1 2 3 	Ly. 1, 23 or Ly. l, 23 k , 
have been associated with particular cellular functions. For example 
Ly. 1+,  23 assist the responses of other cells (Cantor, Shen & Boyse 
1976, Hüber et al 1976) while those that are Ly. 1, 23 act as 
suppressors (Cantor & Boyse 1976, Herzenberg et al 1976). In addition, 
T cells can be subdivided on the basis of the expression of la antigen 
and receptors for the Fc fragment of imunoglobin (Ig). Suppressor 
T cells and a subpopulation of T helper cells are Ia+ve (Okamura et al 
1977, Parish & Mackenzie 1977, Tada et al 1978), while suppressors, 
but not helper, cells are Fc receptor positive (Stout & Herzenberg 
1975, Leclerc 1977, Fridman et al 1977). 
B cells can be distinguished from T cells by the possession of 
surface immunoglobin (Ig) antigen receptors. Each B cell has antigen 
receptors of just one specificity. The origin of the extensive repertoire 
of different specificities (estimates in the region of lO per 
individual have been suggested (Köhler 1976)) is not clear. However, 
the recent discovery that small pieces of DNA can be shunted around 
and recombined within the cell provides a system whereby DNA, coding 
for the variable region of an Ig molecule, can be spliced to that coding 
for the constant region. Thus the amount of information carried in 
the genome that would otherwise be necessary to account for the extreme 
genetic variability of antigen specificity would be reduced. 
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All cells possess the genetic information to make several 
isotypes of immunoglobin. In the adult animal the majority of cells 
carry 1gM on their surfaces and most of these also carry IgD. With 
the exception of IgD, the surface Ig isotype represents the class of 
Ig that the cell will secrete after antigen stimulation. The 
expression of IgD appears to be associated with the ability of B cells 
to respond to those antigens that require T cell help for a maximal 
antibody response (T-dependent antigens: TD) (Zitron et al 1977, Mosier 
et al 1977, Cambier et al 1978). Most mature B cells also have surface 
Ia antigens (Hämmerling et al 1974), receptors for the third component 
of complement (C3R: Bianco et al 1970) and receptors for the Fc portion 
of Ig molecules (FcR: Basten et al 1972). Functional distinctions 
have been made between subpopulations of B cells that are able to 
respond to TD antigens and those which are not (Playfair & Purves 1971 
Gorczynski & Feldman 1975). A further distinction has been made by 
Mosier et al (1977) between populations of B cells that can respond to 
different subgroups of T-independent (TI) antigens (antigens able to 
elicit an antibody response in the absence of T cells). 
During ontogeny, thymic lymphocytes derive from blood—borne 
progenitors which seed into the embryonic thymus (Owen & Ritter 1968 
Moore & Owen 1967, Ritter 1978), a process which may continue during 
adult life (Ford & Micklem 1963, Ford et al 1966, Leuchars et al 1967, 
Micklem et al 1968). The absence of erythroid precursors from the 
thymus (Micklem et al 1976) suggests that, at least in the adult, such 
thymocyte progenitors are already committed to a single line of 
differentiation. 
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Thymocyte precursors have been demonstrated in the adult bone 
marrow by a variety of authors (Komuro, Goldstein & Boyse 1975, 
Roelants et al 1976, Kadish & Basch 1976). The thymus which is 
regenerating after irradiation appears to be repopulated by a small 
number of dividing cell clones (Micklem et al 1972, 1975a, Wallis et 
al 1975, Kadish & Basch 1976). Wallis et al (1975) also showed that 
the time of repopulation was related to the number of bone marrow cells 
injected, implying that the number of available thymocyte progenitors 
might be a limiting factor in regeneration of the thymus. Other data 
however suggest that the number of potential thymocyte progenitors 
in the bone marrow might be quite large (Komuro et al 1975, Roelarits 
et a11976). T lymphocytes mature under the influence of the thymic 
epithelium. Large numbers of thymocytes are produced, the majority 
of which die in the thymus (Feinendegen et al 1973, Shortman 1977). 
It appears however that at least a proportion of those cells that 
are produced by division in the thymic cortex migratesout of the 
thymus via the medulla (Weissman 1973, Fathman et al 1975). A 
maturational sequence has been suggested between cortical cells 
bearing high concentrations of Thy. 1 and low concentrations of 
histocompatibility antigens (high Thy. 1, low H 2 ) which are 
cortisone sensitive and immunologically inactive and low Thy. 1, 
high H 2 , cortisone resistant, immunologically active medullary 
cells (Weissman 1973). Other data, however, suggests that cortical 
and medullary thymocytes develop independently of one another 
(Shortman & Jackson 1974, Shortman 1977, Papiernik et al 1977). In 
addition, it appears that at least a proportion of the peripheral T 
cell population has the characterisitics of cortical thymocytes 
(Shortman et al 1975, Droege 1976, Weissman et al 1976, Callard & 
Basten 19781 suggesting that cortical cells may be the immediate 
progenitors of some immunocompetent peripheral T cells. 
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The main site of B cell differentiation in birds is the bursa 
of Fabricius, where, like the thymocytes, they are descended from 
blood precursors that invade the bursa (Moore & Owen 1967, Le Douarin 
et al 1975). In mammals several tissues provide the specific micro-
environment necessary for B cell differentiation. In the foetus the 
main site of B cell production is the liver (Owen et al 1977), while 
in the adult most B cells are produced in the bone marrow (Lafleur et 
al 1973, Osniond & Nossal 1974, Rosse et al 1978). Experiments 
designed to detect B cell progenitors in foetal liver and adult marrow 
have suggested that they have cytoplasmic 1gM (the first immunoglobin 
isotype detected during ontogeny) but not surface 1gM (Raff et al 1976 
Owen et al 1977). There appears to be a maturational sequence from 
cytoplasmic 1gM +ve precursors to surface 1gM +ve lymphocytes (Raff 
1976, Owen et al 1977). There are, however, some data that suggest 
that pre-B cells may have surface 1gM, possibly with a very short life 
(Melchers et al 1975). After birth B cells acquire the other marks 
of B lymphocyte differentiation: surface IgD (Kearney et a11977), 
C3 receptors (Rosenberg & Parish 1977) and la antigens (Kearney et al 
1977). Hammerling et al (1976) have proposed a maturational sequence 
whereby surface Ig -ye pre-B cells sequentially acquire surface Ig, 
Ia antigens and finally C3 receptors. The final stage of B cell 
maturation is antigen-driven and results in the production of 
specific antibody and the generation of B memory cells. Memory cells 
express the surface irnmunoglobin that indicates the isotype and 
allotype commitment of its progeny antibody forming cells (Okumuro 
et al 1976). In addition, memory cells may also express surface 
IgD (Black et al 1978). 
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Evidence discussed in the previous chapter has shown that serial 
transfer of bone marrow haematopoietic stern cells results in a 
severe depletion of the ability of these cells both to self-renew 
and to regenerate the haematopoietic system of lethally irradiated 
mice. Previous work by Ogden and Micklem (unpublished) has suggested 
that this decline in stern cell function is also reflected in a 
decreased ability of descendant lymphoid cells to (a) mount a 
graft versus host (GvH) reaction, and (b) generate an antibody 
response to sheep red blood cells (SRBC). The experiments described 
here investigated further the immunocompetence of lymphocytes 
descended from multip1.transplanted bone marrow stem cells. 
TI antigens which are able to elicit an antibody response in 
the absence of I cells allow the antibody-forming response of B cells 
to be assayed independently of T cells. The TI antigen chosen to 
monitor B cell function in recipients of serially transplanted bone 
marrow was Sill polysaccharide (Sill). Neonatal thymectomy does 
not influence the responsiveness of C3H mice to Sill (Baker et al 
1973), and Humphrey,. Parrot and East (1964) have shown that congenitally 
athymic (flu/flu) mice develop a plaque forming cell (PFC) response 
to Sill identical in magnitude to that of phenotypically normal 
littermates. In addition, the antibody produced in response to Sill 
is predominantly 1gM (Howard et al 1971a), the production of which has 
been shown to be relatively thymus—independent (Taylor & Wortis 1968). 
I cell activity was monitored using the skin—sensitizing agent 
oxazolone, Davies et al (1969) showed that cutaneous sensitization 
with oxazolone leads to intense paracortical hyperplasia of the 
regional lymph nodes. This cellular proliferation is highly thymus—
dependent (Parrott & de Sousa 1966, Pritchard & Micklem 1972) and is 
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followed by germinal centre activation and antibody production. The 
early T-dependent proliferation to oxazolone was measured in recipients 
of serially—transplanted bone marrow. 
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MATERIALS AND METHODS 
Mice 
Mice used in these experiments were females of the CBA, CBAT6T6 
and (CBA x CBAT6T6)F 1 strains described in the previous chapter. 
Outbred congenitally athymic nu/nu mice from a stock 
maintained in the laboratory were also used. 
Serial transplantation of bone marrow cells, lethal irradiation and 
the preparation of cell suspensions 
As described in the previous chapter. 
Antigens 
Purified type III pneumococcal polysaccharide (Sill) 
preparation B and dextran B512 were the gifts of Dr. J. G. Howard. 
The properties of these preparations have been described elsewhere 
(Howard et al 1971a, Howard & Courteriay 1975, Howard et al 1975). 
The required dose of both antigens was injected intra-venously (IV) 
in 0.2m1 of PBS pH7.2 (see Appendix). Control mice received PBS 
alone. Oxazolone (4-ethoxymethylene-2phenyl-oxazolone, BDH chemicals) 
was administered by pipette to the shaven left flank dissolved in 
O.OSrnl of ethanol heated to 60°C. Control mice received hot ethanol alone 
and were caged separately. 
Assay of antibody production 
Anti-Sill and anti-dextran antibody secreting cells (PFC's) were 
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detected using a modified haemolytic plaque assay (Howard et al 1971à. 
Circulating antibody was assayed by haemaglutinatjon of Sill coated 
sheep erythrocytes (SRBC). 
Sensitizing of target SRBC 
SI'' 
Crude pneumococcal culture filtrate was used to sensitize 
indicator SRBC for the anti-Sill plaque assay (Askonas et al 1966). 
Diplococcus pneumoniae organs were cultivated for 12-16 hours at 37 0 C 
in 0-Meara's medium (see Appendix) supplemented with 1% (v/v) sterile 
mouse blood. The organisms were then killed by the addition of 
formaldehyde to a final concentration 1.5% (v/v) and left at 37 °C for 
4 days, The bacteria were removed by centrifugation at 1,600g for 
30 minutes and the supernatant containing the crude polysaccharide 
dialysed against PBS to remove the formaldehyde. The filtrate was 
stored in 3m1 aliquots at -60° C. 
SRBC were washed 4 times in physiological saline. 0,lml of 
packed cells were then added to 2.0ml of filtrate and the volume 
adjusted to lOml with PBS. This volume of filtrate had been found 
in preliminary experiments to give optimal sensitization of eryth-
rocytes both for the plaque assay and the haemaglutinatjon assay. 
Cells were incubated for 1 hour at 37 0C, washed twice in PBS and 
once in magnesium saline (l%MgSO 4 .7H 2 0 in 0.85%NaC1) and 
resuspended in magnesium saline to a concentration of 10%. Control 
erythrocytes were incubated with 2.Oml of O'Meara's medium. 
Dextran B512 
SRBC's were sensitized with 0-stearoyl dextran B512 kindly 
provided by Dr. J. G. Howard. lml of stearoyl dextran at a 
concentration of 80#g/ml was incubated at 37 ° C for 30 minutes with 
18m1 of saline and lml of packed SRBC. The erythrocytes were 
washed twice in saline and once in magnesium saline and resuspended 
at a concentration of 1% in magnesium saline. These sensitized cells 
were used both for haemaglutination and the plaque assays. 
Direct PFC assay for SII and dextran 
Spleen cell suspensions were prepared as previously described 
in ice cold Dutton's solution (see Appendix). The plating mixture 
consisted of equal volumes of 1.8% agarose (L'Industrie Biologique 
Francaise) v/v in distilled water and 2 x concentrated Dutton's 
solution containing 1% BSA (Armour Fraction v). To 2ml aliquots 
kept at 47°C were added 0.1 1, of the sensitized SRBC and O.lml of the 
spleen cell suspension. This mixture was inverted to mix and poured on 
to 9cm Sterilin petri dishes and allowed to set in an even layer. 
The conventional bottom layer was omitted. The petri dishes were 
incubated for 2 hours at 37 °C in a humidified incubator. 1.5ml of 
guinea pig serum, absorbed with SRBC, diluted 1:50 (v/v) in Dutton's 
was added to each plate. The plates were incubated for a further 
hour at 37°C. Duplicate plates were set up where the plating mixture 
contained 0.2ml of the immunizing solution of Sill or dextran as a 
specificity control. The number of plaques was counted on a 
Scientifica plaque counter using dark ground illumination and slight 
magnification. The number of plaques against control SRBC was 
subtracted from the number against sensitized SRBC to remove the 
natural background PFC's to SRBC. Both the total number of PFC's per 
spleen and the number per 
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  cells were calculated. The results were 
expressed as the geometric mean for each group ± S.E. 4-5 mice 
were used per group. This technique detects only PFC's secreting 
antibody capable of direct lysis of SRBC; mainly 19s antibody (1gM). 
Haemaglutination assay for circulating antibody 
Circulating 19S (2 mercaptoethanol-2ME-sensitive) and 7s 
(2ME-resistant) antibody in serum withdrawn at intervals after 
immunization was quantified using the haemaglutination assay. 0.05m1 
of each sample was diluted serially in gelatin - PBS (PBS pH 7.2 
containing 0.1% gelatin) in Cooke 'v' bottomed microtitre plates. 
0.05m1 of a 1% v/v solution of either sensitized or control blood 
that had received a final wash in PBS was added to each well. A third 
row received sensitized blood containing 0.lM 2ME. The plates were 
then incubated, covered, for 1 hour at 37 °C and overnight at 4 °C. 
The titre was read as the highest dilution of serum exhibiting 
macroscopic haemaglutination. The supernatant was removed without 
disturbing the pellet from the wells containing 2ME and 0.lml of a rabbit 
anti-mouse IgG diluted l:lOO(v/v) was added. The addition of this 
dilution of rabbit serum had been shown previously not to affect the 
19s(IgM) antibody titre but to markedly increase the titre and hence the 
sensitivity of the 7s(IgG) antibody. Results are expressed as the Lo 92 
of the geometric mean ± S.E. 
LUM 
Response to oxazolone 
DNA synthesis and thus the proliferative response to oxazolone 
was determined by measuring the incorporation of radio-labelled 
I-UdR(5-iodo-2-deoxyuridine _'25I)  (Radiochemical Centre, Amersham) 
as described by Pritchard and Micklem(1972). Three days after cutaneous 
sensitization with oxazolone the mice were injected with 5 x 10 8M 
5-fluoro-deoxyuridine(F-UdR) intra-peritoneally (IP) followed an 
hour later by,l,.Ci 125 1-UdR by the same route. The left (draining) 
and right (contralateral) brachial and axillary lymph nodes and the 
spleen were excised and fixed in 70% ethanol. Free 125 IUdR was washed 
from the tissues with several changes of ethanol until the wash was 
free of radioactivity. Tissues were counted either individually 
(spleen) or in pairs (lymph nodes) for 10 minutes on a Nuclear 
Enterprise automatic gamma counter. The radioactivity of the injected 
dose was determined, and the counts adjusted to an injected dose of 
106 counts per minute after subtraction of the background. Uptake 
into organs was expressed as the Log 10 of the geometric mean for 4-5 
mice per group., 
Statistics 
E1 
Differences between groups were analysed using Students T test. 
RESULTS 
Antibody response to Sill 
PFC response 
Howard et al (1971b)found l-lQg of Sill to be the optimal 
immunizing dose in CBA mice. Preliminary experiments confirmed this 
result and showed that the splenic PFC response reached a maximum on 
day 5 (Fig 2.1). For the purposes of these experiments mice were 
immunized IP with 5p.g Sill and the splenic PFC response was assayed 
on days 5 and 7 unless otherwise indicated. 
In the experiment shown in Fig 2.2 the response per spleen to 
Sill in intact (Normal) mice was compared with that in lethally 
irradiated recipients of normal marrow ('Transfer 1' mice) or marrow 
which had been transplanted twice previously ('Transfer 3' mice). 
Irradiated mice were immunized 8 weeks after reconstitution. Irradiated, 
repopulated mice gave a response only 18% of that seen in normal mice, 
confirming results of Howard et al (1971b) who described an 80-93% 
reduction in the PFC response of irradiated CBA mice reconstituted 
with syngeneic bone marrow 2 months previously. There was no 
significant difference between the responses of "Transfer 1' and 
'Transfer 3' mice although 'Transfer 1' animals did respond slightly 
better on day 5. The response in this experiment was reduced by 
about tenfold compared with subsequent experiments. The reason for 
this is unknown. 
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Fig. 2.1 Direct plaque-forming cells in the spleens of normal mice at 
intervals after i.v. injection of g Sill. 	mice/group. 	The mean 
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Fig. 2.2 Splenic plaque-forming 
of Sug Sill. ( C) ) normal mice; 
( A ) ' Transfer I, mice : 8 weeks 
4-5- mice/group. Saline controls 
between groups - the hatched area 
groups t 9% confidence limits. 
cells 5 x 7 days after i.v. injection 
( 0 ) ' Transfer 1' mice; 
after bone marrow transfer. 
showed no significant difference 
represents the mean value for all 
[;1 
mice) or 3 times ('Transfer 4' mice) immunized 10 weeks after trans-
plantation gave a response only about 7-12% of normal on day 5.(Fig2.3). 
Again, although the difference was not statistically significant, mice 
repopulated with an earlier transfer generation of stem cells 
responded slightly better, 
Normal splenic cellularity (Table 2,1) and a reduced response per 
106 cells (Fig 2.4) implies that there is a reduction in Sill responsive 
cells in the spleens of irradiated, reconstituted mice which increases 
with the number of times the repopulating stem cells have been 
transplanted. An alternative explanation is that the peak response 
to Sill is delayed in irradiated reconstituted mice. Gregory and 
Lathja (1970) have described a delay of 24 hours at least initially 
in the response to SRBC, which is no longer apparent by 8 weeks, The 
evidence here (Fig 2.3) however suggests that recipients of trans-
planted marrow have a day S peak response. 
Using another TI antigen dinitrophenylated flagellin (DNP-FLA), 
Nossal and Pike (1973) demonstrated a 50% recovery of the antibody 
response 16 days after irradiation and reconstitution with foetal 
liver. This rose to 80% by 9 weeks suggesting that, at least with 
foetal liver stem cells, an almost complete regeneration of DNP-FLA 
responsive B cells could be obtained given enough time. Since 
it seemed probable that this could also be true of the response to 
Sill, irradiated repopulated mice were tested again at 20-21 weeks 
(Fig 2.5, Fig 2.6). Fig 2.5 shows recovery of the response in 
'Transfer 1' mice from 28% of normal at 8 weeks to approximately 
70% by 21 weeks, A similar experiment (Fig 2.6) assayed the 
response of 'Transfer 1' and 'Transfer3' mice 20 weeks after trans- 
TABLE 2.1 
The number of cells in the spleens of normal and irradiated bone 
marrow (BM) reconstituted mice 
Mice 
	
Number of cells/spleen 
10' t S.E. 
EXPERIMENT 1 * 
Normal mice 	 126 ± 9 
Transfer 2 mice 	 135 ± 12 
Transfer 4 mice 	 130 ± 14 
EXPERIMENT 2 ** 
Normal mice 	 127 ± 3 
Transfer 1 mice 	 120 ± 6 
Transfer 3 mice 	 137 - +  21 
* 	Mice scrificed S weeks after irradiation and reconstitution with 
5 x 10 BM cells 
** 	Mice scrificed 20 weeks after irradiation and reconstitution with 












..... 	 .............. 	 ......... 	 ............ 	
.. ..	
.. 	 .............. ... 	 ...... .. .... ..  
................. 
.......................... 	 ....... 
........................ .............. 
3 	 - 	 7 
Days 
Fig. 2.3 Splenic plaque-forming cells 3, 5 anddays after i.v. 
injection of i.ig Sill. 	( 	) normal mice; ( 	) 'Transfer 2' 
mice; ( A ) ' Transfer L' mice : 10 weeks after bone marrow 
transfer. 	mice/group. Saline controls showed no significant 
difference between groups and the hatched area represents the mean 
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Fig. 2.4 Plaque-forming cells/10 6 spleen cells 3, S and 7 days 
after i.v. injection of Sg Sill. 	( ("))  normal mice; 
C ) ' Transfer 2' mice; ( ) 'Transfer 4 1 mice : 10 weeks 
after bone marrow transfer. 4-5 mice/group. Saline controls 
showed no significant difference between groups and the hatched 














Fig. 2.5 Splenic plaque-forming cells 5 and 7 days after i.v. 
injection with 5tg Sill. 	( 0 ) normal mice; ( 	) 'Transfer 1' 
mice 8 weeks after bone marrow transfer; ( 	) ''Transfer 1' 'nice 
21 weeks after bone marrow transfer. 4-5 mice/group. Saline controls 
showed no significant difference between roups and the hatched area 














Fig. 2.6 Solenic plaque-forming cells 5 and 7 days after i.v. 
injection with g Sill. 	C 0 ) normal mice; (on ) 'Transfer it 
mice; ( 	) 'Transfer 3 1 mice : 20 weeks after be marrow transfer. 
4-5 mice/ group. Saline controls showed no significant difference 
between groups and the hatched area represents the mean value for all 
groups ± 9% confidence limits. 
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plantation. Again 'Transfer 1' animals responded at near normal 
levels (approximately 80%) by this time. 'Transfer 3' mice also showed 
an increase response with time to about 12% of normal compared with 
5% at 10 weeks (Fig 2.2). 
Serum antibody titres 
The level of circulating antibody produced in response to Sill 
was assayed in recipients of serially transplanted bone marrow using 
the haemaglutinatjan test. Fig 2.7 shows the haemaglutinin titre of 
/ffl(nL)fl 
serum from normal 'Transfer 2' and 'Transfer 4' micetlo weeks 
post-transfer. The level of serum antibody was still rising on day 7 
in contrast to the PFC response which peaked on day 5 (Fig 2.1). 
Irradiated reconstituted mice had less circulating antibody than 
normal mice and 'Transfer 2' mice responded better than Transfer 4' 
/"xt 20 u.) ki 	 O.MS 
mice at least on day 7. 	 j2.epopulated micsti11 had sub- 
normal levels of circulating antibody (Fig 2.8). 'Transfer 1' mice 
responded better than 'Transfer 3' mice. The subnormal levels of 
haemaglutinating antibody in the circulation of recipients of normal 
marrow at a time when the day 5 PFC response is practically normal is 
probably explained by the partial or total elimination of serum anti-
body by non-catabolisable antigen reported by Howard, Zola, Christie 
and Courtney (1971c). These authors suggest that the level of serum 
antibody does not give a true measure of response to Sill. No 2ME-
resistant antibody (IgG) could be detected even when an anti-IgG 
developing serum was used confirming the class of antibody produced 
as predominantly 1gM (Howard et al 1971à). 















Fig. 2.7 Titres of haernaglutinating antibody in the sera of mice 
3, and 7 days after i.v. injection of 	Sill. 	( Q ) normal 
mice; ( 	) 'Transfer 2' mice; ( L ) ' Transfer !' mice 
10 weeks after bone marrow transfer. 	mice/group. Saline 
controls showed no significant difference between grous and the 









Fig. 2.8 Titres of haemaglutinating antibody 
and 7 days after i.v. injection of 	Sill. 
( El ) ' Transfer 1' mice; ( 	) 'Transfer 3' 
afr bone marrow transfer. 4-5 mice/group. 
showed no significant difference between groups 
area represents the mean value for all groups ± 
in the sera of mice 
( 0 ) normal mice; 
mice : 20 weeks 
Saline controls 
and the hatched 
9% confidence limits. 
The results of these experiments indicate 2 things: 
The recovery of the PFC response to Sill in irradiated bone 
marrow reconstituted mice (radiation chimaeras) is a slow process. 
Mice reconstituted with multiply—transplanted bone marrow 
show a progressive reduction in response with transfer, 
Adoptive PFC response 
While the most obvious explanation for the reduced response in 
irradiated, repopulated mice is a lack of immunocompetent B cells 
recognizing Sill, an increase in cells suppressing the response would 
have the same effect. Cells that both amplify and suppress the anti-
body response to Sill have been described (Baker 1975) and the 
following experiments were designed to detect their presence in 
radiation chimaeras. Spleen cells from normal or chimaeric mice were 
injected either separately or together into lethally irradiated 
recipients. The recipient mice were challenged with 5,&g SIll 24 hours 
later, and assayed for splenic PFC on days 5 and 6. The number of 
PFC per spleen in recipients of several doses of normal cells on day 
5 and 6 of the response is shown in Fig 2.9 and Fig 2.10 respectively 
10  cells failed to give a response above background on day 5 but for 
higher cell doses the number of PFC per spleen increased linearly with 
the number of cells injected on a Log/Log plot (Fig 2.9). The slope 
of the graph was 1.72. By day 6 (Fig 2.10) the slope of the response 
was reduced to 1.2. 
A number of authors (Celada 1967, Kontainen & Mäkelä 1968, 
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Fig. 2.9 Day 5 splenic plaque-forming cell response in lethally—
irradiated mice immunized i.v. with 5iig Sill 24 hours after the 
i.v. injection of graded doses ofnormal syngeneic spleen cells ( 0 ). 
Control mice received saline ( • ). The hatched area represents 
the mean of the day 5 response in intact animals - 9% confidence 
limits. 	4-5 mice/group. Cc+/ fvicE 	 (JSt2d- q 	LL 
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Fig. 2.10 Day 6 splenic plaque-forming cell response in lethally 
irradiated mice immunized i.v. with 5Lg Sill 24 hours after the i.v. 
injection of graded doses of normal sigeneic spleen cells ( 0 ). 
Control mice received saline ( • ). 	 L- mice/group. cO,,+i'o/5 rEce' v6d_ 
c.'tsfe 	4 2Z1. 
cells primed with a variety of T-dependent (TO) antigens are transferred 
into irradiatied recipients and rechallenged. This 'premium effect' 
indicates that more than one synergising cell population is involved 
in the response. A single non-interacting limiting cell type should 
give a slope close to 1, and 2 co-operating populations a slope of 2. 
The slope of 1.7 for day 5 of the response to Sill implies that 2 
limiting cell types co-operate in the synthesis of antibody to this 
antigen. A premium effect is most apparent when the antibody titre is 
increasing rapidly (Janeway 1975). As the response reaches a maximum 
the action of regulator cells leads to a flattening of the slope. 
This probably explains both the decreased slope of day 6 (Fig 2.10) 
and the slope of less than 2 on day 5 (Fig 2.9), since the response 
has reached a maximum by this time, at least in intact animals (Fig 2.1). 
One of the limiting cell types is presumably the Sill reactive 
B cell and as I cell involvement in the response to Sill has been 
described (Baker 1975) it seemed possible that the second cell was a 
T cell. In an attempt to elucidate the nature of this second cell 
the above experiment was repeated using CBA and congenitally athymic 
flu/flu mice as spleen cell donors. The recipients were lethally 
irradiated CBA mice in both cases. 
The results shown in Fig 2.11 show the day 5 slope for CBA spleen 
cells as 1.78, but the slope for flu/flu mice was only 0.24. This result 
suggests that one of the cells involved in the response to SIll is 
absent from flu/flu mice and might therefore be a T cell. Interpre-
tation of the results however, is complicated by the fact that the 
flu/flu donors and the CBA recipients were not syngeneic and it cannot be 
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Fig. 2.11 Day 5 splenic plaque-forming cell response to Sill in 
lethally-irradiated recipients of graded doses of normal syngeneic 
spleen cells ( 0) or outbred nu/nu spleen cells ( L, ). The mice 
were immunized i.v. with 5LLg Sill 24 hours after the spleen cell 
injection. Control mice received saline ( • , A ). 	L-S mice/group. 
Con -froI (ece • vcL. 	 c-r 	.i.d. Cf Si??. 
reaction on the part of recipient mice. The very shallow slope using 
nu/nu donors implies suppression since a single non-interacting cell 
type should give a slope of 1, but whether this is due to the above 
mentioned histo-incompatibility or to suppressor cells is not clear. 
The high background reactivity to Sill in this colony of nu/nu mice 
(Fig 2,11 and Briscoe 1974) suggests a long-standing immunization 
which might be expected to generate suppressor cells. In order to 
clarify the question of T cell help in the anti-Sill response it 
would be necessary to repeat this experiment using either histo-
compatible nude mice or T-depleted CBA spleen. 
The day 5 adoptive primary response of spleen cells from 
irradiated ) bone marrow-reconstituted mice was then compared with that 
of normal cells. Fig 2.12 shows the number of PFC in the spleens of 
recipients of 2 x lO cells from either normal or 'Transfer 1' mice 
plotted alongside the results from Fig 2.9. The 'Transfer 1' mice had 
been irradiated and reconstituted 8 weeks previously. A third group 
received 2 x lO cells of each type. 2 x 10 normal cells responded 
as predicted from Fig 2.9, but 2 x lO 'Transfer 1' cells gave a 
response equivalent to half this number of normal cells. This result 
is in accordance with the reduced response of intact 'Transfer 1' mice 
and rules out a failure of irradiated reconstituted mice to process 
antigen correctly as a explanation for sub-normal antibody production. 
Recipients of 2 x lO cells of each type gave an additive response 
There was therefore no evidence of suppressor cells operating to reduce 
the response of 'Transfer 1' mice at this stage in this experimental 
system. This was confirmed in a repeat experiment in which the adoptive 
response of equal numbers of spleen cells from normal and 'Transfer 1' 
M1 
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Fig. 2.12 Day 5 splenic plaque-forming cell response to Sill in 
lethally irradiated recipients of graded doses of nrrnal spleen cells 
( 0 ), 2 x 107  normal spleen cells ( 	); 2 x 10' 'Transfer 1' 
spleen cells : • 
); 
2 x iO normal spleen cells + 2 x io7 'Transfer 1' 
spleen cells A ). The mice were immunized i.v. with 5ig Sill 
2Li. hours after the injection of the spleen cells. 	Transfer of bone 
marrow had taken place 8 weeks previously. 4-5 mice/group. 
100 
mice, 8 and 21 weeks post-transfer, was measured (Fig 2.13). Cells 
from 'Transfer 1' mice donors showed aIight1y subnormal response both 
at 8 and 21 weeks, but failed to suppress the response of an equal 
number of normal cells. The results of the experiment shown in Fig 2.14 
however, g'íe an indication that suppressor cells might be involved in 
the response to Sill. Cells from 'Transfer 2' and 'Transfer 4' donors 
gave a subnormal adoptive response with cells from the earlier transfer 
generation doing slightly better. Injecting normal cells with 'Transfer 
4' cells gave the expected additive effect, but normal cells plus 
'Transfer 2' cells gave a. response that was less than normal cells alone. 
This suggests that there are cells present in 'Transfer 2' spleen 
capable of suppressing the response of normal cells, but this is 
the result of only one experiment and would need to be confirmed. 
From these experiments it can be concluded that: 
2 limiting cell populations are co-operating in the response 
to Sill, one of which may be a T cell. 
The subnormal response of irradiated mice repopulated with 
normal and multiply—transplanted bone marrow stem cells is 
probably not due to an excess of suppressor cells. 
Antibody response to dextran B512 
A premium effect similar to that shown here for Sill has also been 
described for another TI antigen DNP-POL (Stocker et al 1974). It 
therefore seems likely that co-operation between immunocompetent cells 
is a characteristic of the response to many TI antigens. The experiments 
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CELL DOSE (x1O) 
Fig. 2.13 Day 5 spleriic plaque-forming cell response to Sill in 
lethally irradiated recipients of graded doses of noxnal spleen cells 
( o ); i x i07 normal spleen cells ( •); 1 x 10 'Transfer 1' 
spleen cells either 8 weks ( A ) or 21 weeks ( 0 ) after bone 
marrow transfer; 1 x lO normal spleen cells + 1 x lO 'Transfer 1' 
spleen either cells 8 weeks after bone marrow transfer ( L ) or 
21 weeks after bone marrow transfer ( [J). The mice were immunized 
i.v. with 5ug Sill 24 hours after the injection of the spleen cells. 
Li- mice/group. 
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CELL DOSE (x10) 
Fig. 2.14 Day S splenic plaque-forming cell response to Sill in 
lethally irradiated recipients of graded doses o± normal spleen 
cells ( 0 ); 2 x 107 normal spleen cells • ); 2 x 1O 'Transfer 2' 
spleen cells 	); 2 x 107 'Transfer ' p 	ra lee cells 	A); 
2 x io normal 1 	
LL 
een cells + either 2 x 10 1  'Transfer 2' spleen cells 
C 	) or 2 x 1-0 'Transfer LL' spleen cells ( 	). 	The mice were 
immunized i.v. with 5p.g Sill 2L hours after the injection of the 
spleen cells. Bone marrow transfer had taken place 10 weeks 
previously. 4-5 mice/group. 
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described below show that this is true at least for dextran B512 and 
that one of the co-operating cell populations is probably thymus 
dependent. 
The antibody response to dextran B512 has been shown to be inde-
pendent of T cell help (Fernandez & Möller 1977). In accordance 
with previous work by Howard et al (1975) the optimal immunizing dose 
of dextran was found to be between 1 and 10g (Fig 2.15). 2,&g was 
chosen as the immunizing dose for all experiments. The number of 
splenic PFC's rose to a peak on day 5 and slowly decreased thereafter 
(Fig 2.16). Serum antibody reached a maximum on day 7 (Fig 2.17). 
No IgG could be detected in the serum even when 2-ME resistant antibodies 
were developed with rabbit anti-mouse IgG. 
A slope of 1.82 for the adoptive 1 ° response of normal CBA spleen 
cells to dextran (Fig 2.18) demonstrated that like Sill and DNP-POL 
the production of antibodies to this antigen involves the co-operation 
of 2 limiting cell populations. That the slope is reduced to 0.83 if 
nude mice are spleen cell donors suggests that one of these cell 
types is thymus dependent. However, since the donor nu/nu mice and 
the recipient CBA mice are not sygeneic it is possible that the 
reduction in slope merely represents an immune reaction by the 
recipient. 
Response to oxazol one 
Cellular proliferation following sensitization with oxazolone 
was measured by the incorporation of radio-labelled 5-iodo-2-deoxyuridine 
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Fig. -2-15 Day 5 splenic plaque-forming cell response in normal mice 
to graded i.v. doses of dextran 3512. 	The hatched area represents 
the mean of the saline controls ± 95% confidence limits. 4-5 mice/ 
group. 
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Fig. 2.16 The splenic plaque-forming cell response in normal mice 
at intervals after i.p. injection of 2p.g of dextran B12. The hatched 
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Fig. 2.17 Titres of haemaglutinating antibody in the sera of normal 
mice at intervals after i.v. injection of 2.Lg of dextranBSl2. 	The 
hatched area represents the mean of the saline controls - 95% 
confidence limits. 4-5 mice/group. 
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Fig. 2.18 Day 5 splenic plaque-forming cell response to dextran in 
lethally irradiated CEA recipients of graded doses of normal syngeneic 
spleen cells ( 0 ) or outbred nu/nu spleen cells ( 	). Control 
mice received saline • , ). The mice were injected i.v. with 
2pg of dextran 'B512 2L hours after the injection of the spleen cells. 
The hatched area represents the day 5 response in intact CBA mice 
95 confidence limits. L-S mice/group. 
when maximum incorporation of 125 1-UdR has been shown to occur at 
least in intact mice (Pritchard & Micklem 1972). Preliminary 
experiments to determine the optimal sensitizing dose of oxazolone 
showed that 125 1-UdR incorporation did not increase significantly for 
Ld(rpk rojE5 of 
doses above 0.1mg in/either intact or irradiated, bone marrow 
reconstituted mice (Fig 219). The response in the repopulated 
animals which had been irradiated and reconstituted 6 weeks prev-
iously was 2-3 times less than that in normal mice. The time course 
of the response to oxazolone in radiation chimaeras is not known and 
it is possible that this reduced 125 1-UdR incorporation is due merely 
to a delay in maximum cell proliferation. 'Transfer 1' mice 
responded slightly better than 'Transfer 3' mice but this difference 
was not significant, 125 1-UdR incorporation is the spleen (Fig 2,20) 
and the contralateral lymphnodes (Fig 21) remained at background levels 
for all doses of oxazolone. In subsequent experiments only the results 
for the draining lymph ro3swill be discussed. 
The response of'Transfer 1' mice remained subnormal until 12 weeks 
after bone marrow transplantation (Fig 2.22). Similar patterns of 
recovery were seen in mice immunized with 10mg and 1mg doses of oxazolone. 
By this time little difference could be detected between normal mice, 
those reconstituted with normal marrow and those reconstituted with 
multiply transferred marrow (Fig 2.23). 'Transfer 1', 'Transfer 2' and 
'Transfer 3' mice gave normal responses at 12 weeks, and only in 
'Transfer 4' animals was 125 1-UdR incorporation significantly below 
normal. 
When lymph node cells from normal mice are transferred into 
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Fig. 2.19 Incorporation of 1251_UdR  into the drainin brachial and 
ad1JLary lymph nodes of normal ( 0 ), 'Transfer 1' ( 	) or 
'Transfer 3' ( 	) mice 3 days after cutaneous sensitization with 
different doses of oxazolone. There was no significant difference 
between control groups the results from which were pooled and 
expressed as the mean - 9% confidence limits (hatched area). 
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Fig. 2.20 Incorporation of 	into the spleen of normal ( 0 ), 
'Transfer 1' ( 	) or 'Transfer 31 ( . ) mice 3 days after cutaneous 
sensitization n different doses of oxazolone. There was no 
significant difference between control groups, the results from which 
were pooled and expressed as the mean ± 95% confidence limits (hatched 
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Fig. 2.21 Incorporation of 12 I-tidE into the contralateral brachial 
and adUar3r lymph nodes of normal ( 0 ), 'Transfer 1' C 	or 
'Transfer 3' ( A ) mice 3 days after cutaneous sensitization with 
different doses of oxazolone. There was no significant difference 
between control groups the results from which were pooled and 
expressed as the mean - 9% confidence limits (hatched area). 
4-5 mice/group. Bone marrow transfer had taken place 6 weeks 
previously. 
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Fig. 2.22 Incorporation of 125 I-tJdR into the draining brachial and 
axillary lymph nodes of lethally irradiated recipients of 5 x 100 
normal bone marrow cells 3 days after cutaneous sensitization with 
1 mg ( fl) and 10 mg ( 0 ) of oxazolone at intervals after injection 
of the bone marrow cells. 4-5 mice/group. The response in 
sensitized intact mice 95% confidence limits (::)• 	The response 
in control intact mice - 95% confidence limits (/7/). 
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12 Fig. 2.23 	1-UdR incorporation in the draining brachial and 
adl1ary lymph nodes of mice 3 days after cutaneous sensitization 
with 10mg of oxazolone 6 and 12 weeks after bone marrow transfer. 
'Transf1' mice ( L ); 'Transfer 2' mice ( 0); 'Transfer 3' 
mice ( I); 'Transfer Li.' mice (4 ); intact mice ± 95% confidence + 
limits :::::); mean of the pooled results from alcohol controls - 
9% confidence limits 	 4-5 mice/group. 
1 14 
proliferative response is achieved 4 days after sensitization 
(Rose 1975). The day 4 response to 1mg of oxazolone in recipients of 
several doses of lymph node cells from normal 'Transfer 1' and 
'Transfer 4' mice is shown in Fig 2.24. Lymph node cells were taken 
12 weeks after bone marrow transfer, 	 P fniil'ort.. - normal 
cells gave a response C!oS€ 	to that seen in the intact mouse. 
Increasing the number of cells transferred above 106 failed 
significantly to increase 125 1-UdR incorporation. Cells from irradiated 
reconstituted mice responded less well than the same number from 
normal mice. It required 3 x 10  'Transfer 1' cells to give a response 
equivalent to that in intact mice and even this number of 'Transfer 4' 
cells failed to give a normal response. This result was slightly 
surprising since by 12 weeks, intact 'Transfer 1' mice are responding 
normally. However, the lymph node cellularity is increased in these 
animals by about 1.5 times (Table 2.2), suggesting that a decreased 
concentration of oxazolone reactive T cells rather than a decline in 
absolute number is responsible for the apparently sub-normal response 
of 'Transfer 1' lymph node cells. The lymph nodes of 'Transfer 4' 
mice had normal cellularity suggesting that the subnormal response in 
these animals is due to a lack of cells proliferating in response to 
oxazol one. 
Summary of results 
(1) The antibody response to Sill in irradiated mice reconstituted 
with normal bone marrow ('Transfer 1' mice) is still only 80% of normal 
by 20 weeks after bone marrow transfer, while the proliferative response 
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Fig. 2.24 125I-UdR incorporation in the draining brachial and acllary 
lymph nodes of lethally irradiated recipients ofgraded doses of 
normal ( 0 ), 'Transfer 1' ( D ) and 'Transfer Li.' ( i ) lymph 
node cells L days after cutaneous sensitization with 1mg of oxazolone. 
(•)M,a)control mice received alcohol.(:::::'.:::: ) represents the response of intact 
mice to 1mg oxazolone and = the alcohol control for intact mice. 
Bone marrow transfer had taken place 12 weeks previously. 4-5 mice/group. 
TABLE 2.2 
The number of cells in the brachial and axillary lymph nodes of 
normal and irradiated bone marrow (BM) reconstituted mice 
Mice 
	
Number of cells x 106 
	
Ratio of normal 
reconstituted 
EXPERIMENT 1* 
Normal mice 	 17 
Transfer 1 mice 	 26 	 1.5 
Transfer 5 mice 	 17 	 1 
EXPERIMENT 2** 
Normal mice 	 16 
Transfer 1 mice 	 25 	 1.6 
* 	Mice sacrifced 12 weeks after irradiation and reconstitution 
with 5 x 10 BM cells 
** 	Mice sacrifced 32 weeks after irradiation and reconstitution 
with 5 x 10 BM cells 
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(2) Serial transfer of bone marrow stem cells results in a 
progressive decline in the antibody response to Sill, but has little 
effect on the proliferative response to oxazolone. 
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DISCUSSION 
Previous results from this laboratory (Ocden & Micklem 
unpublished) suggested that the ability of lethally—irradiated, 
bone marrow—reconstituted mice to mount an immune response is 
inversely proportional to the number of times the repopulating marrow 
has been transplanted. Ogden and Micklem (unpublished) found a 
decrease both in GvH activity (Table 2.3) and in the antibody response 
to sheep red cells (SRBC) (Fig 2.25) with an increase in the number of 
transfers undergone by parent stem cells. The involvement of T cells 
both in GvH reactions and in the antibody response to SRBC makes it 
impossible to say whether both T and B cells or only T cells are 
affected by serial transfer. The experiments described in this chapter 
were designed to assay I and B cell function independently. 
T cell function 
In contrast to GvH reactivity, the proliferative response to 
oxazolone was not greatly influenced by serial transfer. In view of the 
well documented functional and phenotypic heterogeneity of I cells 
(Cantor & Boyse 1975a,b) the most obvious explanation for this result 
is that the two different tests assay different subpopulations of cells. 
It is not clear why some classes of T cells should be more susceptible 
to serial transfer than others, but the answer may lie in the number of 
cells required for a maximal response. 125 1-UdR incorporation, in 
response to oxazolone, was achieved by as few as 10   cells (Fig 224) 
suggesting that a normal proliferative response to oxazolone can be 
achieved by a subnormal complement of T cells. 
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TABLE 2.3 
The graft versus host reactivity*of spleen cells from lethally 
irradiated mice repopulated with normal and serially transferred 
bone marrow (Ogden & Micklem unpublished) 
Transfer number 
	
125 IUdR uptake*** 
draining lymph node/contralateral lymph node 
O** 	 3.64 
1 	 2.71 
2 	 2.78 
4 	 1.84 
5 	 0.99 
* 	(C57BL10 x CBA) F, mice were injected sub-cutaneously in the left rear 
footpad with CBA pleen cells. Control cells were injected into the 
rigrear footpad. The GvH response in the regional node (measured 
by 	51-UdR uptake) was expressed as the uptake ratio (uptake in 
regional node/uptake in contralateral node) (Baines & Micklem 1975) 
** 	Bone marrow transferred at 8 week intervals 
6 (BlO x CBA) F1 recipients/gp 
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Fig. 2.25 The time course of the direct anti-SRBC plaque-f ormin 
cell response in the spleens of normal ( Q ), 'Transfer 1' ( • ), 
'Transfer 31 ( 	) and 'Transfer 5 1 C 	) mice 8 weeks after bone 
marrow transfer. (Ogden & Micklem, unpu lished). 
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The ability to give a peak response with a relatively small number 
of cells may account for the disparity between the rates of recovery of 
Thy.l +ve cells and oxazolone reactive cells in irradiated reconstituted 
mice (Fig 2.26). By 12 weeks, a time when the oxazolone response in 
bone marrow reconstituted mice is almost normal, the number of T cells 
in the lymph nodes of foetal liver reconstituted mice is still reduced 
by 60% (Rozing et al 1977). The use of foetal liver rather than bone 
marrow stem cells probably accounts for some of the delay since bone 
marrow would be expected to contain a few mature T cells (Norin et al 
1978). On the other hand, a direct comparison of foetal liver and adult 
bone marrow cells showed the former to be the most effective long-term 
repopulators of the thymus and lymph nodes (Micklem et al 1972). Thus 
it appears that irradiated, reconstituted mice are able to achieve a 
normal response to oxazol one with a severely reduced complement of T cells. 
It seems probable that a response of this type would be reasonably 
resistant to the effects of a reduction in the regenerative potential 
of precursor stem cells. 
The number of cells needed to generate peak GvH reactivity is not 
known, but since the recovery of this response has been shown to 
parallel closely the recovery of Thy.l +ve cells, at least in the spleen 
(Trier & Rubin 1974) a maximum response appears to be dependent to a 
greater extent on a normal quota of T cells and thus susceptible to a 
reduction in the regenerative potential of precursor stem cells. 
Another sub-class of T cell that may be affected by serial trans-
plantation of parent stem cells is the thymus dependent helper cell 
involved in antibody responses. A number of authors (Aisenberg & Davies 
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Fig. 2.26 The proliferative response to oxazolone in the draining 
brachial and adllary 1inph nodes of lethally irradiated nice 
repopulated with S x 10 normal bone marrow cells at intervals 
after irradiation and reconstitution ( S ). ( 0 ) represents 
the number of Thy.l +ve cells in the lymph nodes of foetal liver 
repopulated mice (Razing et al 1977). 	All values are expressed 
as the % of that seen in intact animals. 
recovery of the antibody response to SP.BC following irradiation and 
reconstitution occurs slowly. Gregory and Lajtha (1970) have suggested 
that the response is limited by the number of available I helper cells. 
A progressive decline in helper T cells with serial transfer might 
therefore account for the increasingly sub-normal anti-SRBC response 
in mice repopulated with serially.-transplanted bone marrow (Fig 2.25). 
B cell function 
So far the evidence suggests that transplantation of haematopoietic 
stem cells results not only in a reduction in their proliferative 
potential but in their ability to generate normal numbers of at least 
some classes of T cells. It does not, however, rule out the possibility 
that B cells are affected also. The response to the TI antigen Sill 
was used to monitor B cell function in recipients of serially—trans-
planted bone marrow. The results showed two things. 
The recovery of the response in radiation chimaeras was 
remarkably slow. By 20 weeks post irradiation it was still only 
80% of normal. 
There was a progressive decline in the ability of recipients 
of serially—transplanted bone marrow to mount a PFC response to 
this antigen. 
If, as is frequently stated, the production of anti-Sill antibody 
is independent of T cell help the simplest interpretation of these results 
would be that serial transfer of bone marrow results in a decline in 
the number of B cells able to react specifically with Sill. However, 
data on the recovery of B cells following irradiation and reconstitution 
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suggest that this explanation may be naive. Rozing et al (1977) 
found that by day 30 the spleens of mice repopulated with foetal liver 
stem cells had a normal complement of Ig +ve cells. B cells specific 
for SRBC took longer to recover, but were normal in number by day 60. 
If the mice were repopulated with bone marrow stem cells, B cell 
recovery occurred even earlier with SRBC-specific cells reaching 
normal levels by day 40 (Van Muiswinkel et al 1975). Thus it appears 
likely that the recovery of Sill reactive B cells probably precedes 
that of a normal anti-Sill antibody response by several weeks. How- 
ever, since different subsets of B cells have been described for TD and 
TI antigens (Jennings & Rittenberg 1976) it may be that these recover 
at different rates. There are even two sub-classes of B cells that 
respond to two different types of TI antigens (rosier et al 1977). 
Those B cells that respond to Sill are thought to be the more mature 
of these groups and it is possible that some maturational step, such 
as the acquisition of surface IgD1 is delayed. 
It should be noted at this point that the sub-normal response of 
radiation chimaeras to Sill was not due merely to an inability of 
irradiated mice to process antigen since cells from these animals 
displayed sub-normal responses when assayed by adoptive transfer (Fig 2.9). 
Alternatively the results could be explained by a requirement for 
a second co-operating cell type, which needs longer to recover after 
irradiation and bone marrow transplantation. There is evidence that 
macrophages are necessary for a normal response to TI antigen (Chused 
et al 1976 , Mosier 1967) but since bone marrow-reconstituted animals 
have normal numbers of these cells in the spleen by 20 days (Kincade 
et al 1975) they do not seem to be very likely candidates. In fact, 
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although Sill is generally considered a T-independent antigen the cell 
which approximates most closely to this hypothetical co-operating cell 
is a T-cell. Since there is now considerable evidence implicating T 
cells in the control of the antibody response to Sill (Baker 1975) 
this is not as improbable as it may appear. Baker's group have described 
cells, absent from nude mite and susceptible to anti-lymphocyte serum 
(ALS), that both enhance and suppress the anti-Sill response. Under 
normal conditions the suppressor cells are generated first and cancel 
the effect of the amplifier cells (Markham et al 1977) which accounts 
for the apparently normal response in T-deprived mice. T cell 
involvement in the response to PVP, another TI antigen, has also been 
described (Rotter & Trainin 1974). 
Evidence for the co-operation of two cell types in the response 
to Sill came from the adoptive response of different doses of normal 
spleen cells. When the log of the number of PFC/spleen was plotted 
against the log of the cell dose (Fig 2.9) a straight line was obtained 
with a slope of 1.7. Since a single non-interacting population of cells 
should give a slope of near 1, this 'premium' effect suggested that 2 
limiting cell populations are co-operating in the response to Sill. 
A premium effect has been described for a variety of TD antigens 
(Celada 1967, Kontainen & Mäkelä 1968, Mitchell et al 1972, Janeway 1975) 
where it has been attributed to a limiting number of helper T, as well 
as B, cells in the system. In the response to Sill one of the limiting 
cells is presumably a specific Sill-reactive B cell. There are at least 
3 possible alternatives for the second cell; another B cell, a 
macrophage or a I cell. 
Stocker, Osmond and Nossal (1974) described a strikingly similar 
slope of 1.7 for the adoptive primary response to another TI antigen 
126 
DNP-POL (a dinitrophenylated polymer of flagellin). Since treatment 
with anti-Thy,l antiserum did not reduce the slope to 1 they concluded 
that B:B cell co-operation was occurring. They claimed support for 
this hypothesis from a failure of anti-Thy.l anti-serum to abolish 
a premium effect to SRBC (Mitchell et al 1972). 
Additional evidence for B:B co-operation has been suggested by 
Del Guercio and Leuchars (1972) at least in the anti-DNP response 
to DNP coupled to a T-independent carrier, levan. Cells tolerant 
to levan failed to help an anti-DNP response when challenged with 
DNP-levan; thymecotomy, while having a profound effect on the response 
to DNP coupled to a TD carrier, had no effect on the response to DNP 
coupled to levan. 
Macrophages are needed in the antibody response to some TI antigens 
(Chused et al 1976). In their functional state, at least, they are 
generally considered to be radio resistant (Roseman 1969) and therefore 
present in excess in recipient mice during adoptive transfer experiments. 
The possibility, however, of a limiting population of macrophages 
co-operating with B cells in the response to Sill cannot be entirely 
ruled out. 
There are several pointers, however, which suggest that the cell 
which co-operates with Sill specific B cells to produce antibody may 
be a T cell. Firstly, it is known now that T cells do in fact regulate 
the antibody response to this and other 'TI' antigens (Baker 1975). 
Secondly, if the response to Sill at intervals after bone marrow 
repopulation, is plotted alongside the value for splenic T cells 
(Rozing et al 197 7) and SRBC reactive B cells (Van Muiswinkel 1975), 
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following reconstitution with foetal liver and bone marrow respectively 
(Fig 2.27), the recovery of the anti-Sill PFC's can be seen to closely 
parallel that of the T cells not the B cells. Finally the absence 
of a premium effect in nude spleens (Fig 2.11) suggests that the response 
may involve I cell co-operation, with the proviso however that this 
may have been due to the fact that the donor and recipient were not 
syngeneic in this experiment. It has been suggested by Baker and 
Prescott (1975) that the method of sensitizing the target erythrocytes 
with a crude pneumococcal culture filtrate such as was used in these 
experiments may result in measuring the response to 2 antigens: Sill 
itself, and 'C'-protein which is a contamirient of many Sill preparations 
In other words, it is not possible to state definitely that the 
involvement of I cells is not due to a T dependent response to 'C'-
protein. However, a similar 'premium' effect has been reported for 
DNP-POL (Stocker et al 1974) and as no trace of serum IgG antibody 
could be detected we consider this explanation to be unlikely. In 
addition, the response to yet another TI antigen, dextran B512, also 
exhibited a premium effect. (Fig 2.18). 
Since whichever cell is 'helping' the antibody response to Sill 
and dextran is not present in excess, it is reasonable to assume that 
it is specific in some way. In an anti-hapten response where the 
hapten is coupled to a T—dependent carrier a requirement has been 
demonstrated, not only for specific recognition of carrier antigenic 
determinants by helper T cells (Mitchison 1971), but also for the gene 
product of the I region of the major histocompatability complex (MHC) 
(Katz et al 1975). Ia antigens are present on B lymphocytes and 
macrophages and recent evidence shows that antigen specific factors 
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Fig. 2.27 The splenic plaque-forming cell response to Sill in 
lethally irradiated mice repopulated with 5 x lo7 normal bone marrow 
cells at intervals after irradiation and reconstitution ( Q). 
The splenic values for Thy. 1 +ve cefls after repopulation with 
foetal liver ( A ) ( Rozing et al 1977) and SRBC reactive B cells 
after repopulation with bone marrow ( 0 ) ( Van Muiswinkel et al 1975) 
are also shown. Values for anti-Sill PFC's and Thy.l +ve are 
expressed as the % of those seen in the intact mouse and the number 
of SRBC-reactive cells as the absolute number. 
Negative selection studies provide strong evidence that individual T 
lymphocytes are able to recognise both Ia antigens and TO antigens 
(Paul & Benaceraff 1976). Other helper cells may be specified for B 
cells bearing a given class (Press et al 1976), allotype (Herzenberg 
et al 1976) or idiotype of imunoglobulin. It is therefore apparent 
that T helper cells are able to recognise T-dependent antigens, I-region 
gene products and B cell Ig determinants. Recently 2 groups (Janeway 
et al 1977, Tada et al 1978) have described 2 distinct types of I cells 
able to act synergistically to help the B cell response. Janeway 
et al (1977) demonstrated that one of their cell populations was 
dependent for its activation on the presence of Ig while Tada et al 
(1978) could detect Ia on one subset of cells but not the other. This 
evidence suggests that in an antibody response to a TO antigen there are 
at least 2 subpopulations of T cells co-operating with the B cell, one 
recognizing antigen in association with I-region products and one 
recognizing the idiotype or, in certain cases, the allotype (Herzenberg 
et al 1976) of specific antibody molecules. A hypothesis of this type 
is supported by data from Herzenberg et al (1976) which demonstrates 
synergy between those cells recognizing Ig allotypes and those that 
do not. 
Baker (1975) has suggested that the T cell..-amplifying the response 
to Sill may require Ig for its activation. It is conceivable, therefore, 
that the cell detected in these experiments may be of the class of T helpers 
that recognize antigen in association with some Ig determinant. It is 
evident from experiments in 1-deprived mice that the initiation of a 
response to TI antigen does not require T cells. It may be, however, 
that T cells assist the response by boosting the proliferatior or perhaps 
maturation ofantibody secreting cells. Muirhead and Cudkowicz (1978) 
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described two populations of T cells that act synergistically in a 
primary anti-hapten response, one of which was carrier-specific and 
activated hapten-specific B cells and the other which was not carrier 
specific but which stimulated the proliferation of activated cells. 
It seems possible therefore that B cells which respond to TI 
antigens are able to become activated by antigen without the aid of 
T cells, but that once activated are receptive to help by a second 
subclass of T helper cells which induce cell proliferation. The T 
cells able to assist in a TI response may be specific not for antigen 
but for some determinant on the B cell antigen receptor, a determinant 
perhaps that is exposed only on those receptors which are combined 
with antigen. Alternatively these 'TI T helper cells' may play some 
role in the maturation of B cells as described by Sherr et al (1978). 
Howard et al (1971b) found that the rosette-forming cell (RFC) 
response to Sill in radiation chimaeras was normal 8 weeks after 
reconstitution, a time at which the PFC response was reduced by 80%. 
It may be that the RFC's lacked some maturational stimulus, perhaps 
provided by T cells, which would enable them to secrete antibody. 
If, as seems probable, T cells do 'help' the antibody response to 
SIll then this antigen cannot be said to r'ieo.sur B cell activity 
independently of I cells. In other words, it is possible that the 
observed decline in the response to Sill in recipients of serially—
transplanted bone marrow may be the result of suboptimal numbers of 
the appropriate T cells in these animals. 
Evidence has been discussed here that suggests that the factor 
which limits the antibody response to both Sill and SRBC after 
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irradiation and reconstitution with normal marrow ('Transfer 1' mice) 
is not a lack of antibody forming cells, which recover fairly rapidly, 
but the time needed to generate sufficient co-operating I cells. How-
ever, the generation of excess suppressor cells in recipients of trans-
planted bone marrow, would also result in an apparent reduction in T 
helper activity. Suppressor cells have been described for the 
responses to TD antigens (Gershon 1974), skin sensitizing agents 
(Thomas et al 1977) and Sill (Baker 1975). If irradiation and 
reconstitution resulted in an initial increase in the ratio of 
suppressors to helpersthen an apparent delay in the generation of 
normal numbers of helper cells might result. A progressive increase 
in this imbalance with transfer could explain the reduced responses 
seen in recipients of multiply-transplanted bone marrow. There is 
evidence from a single experiment (Fig 2.14) that there might be 
excess suppressors in 'Transfer 2' mice at least for the response to 
Sill, but this needs confirmation. 
The reason for the length of time taken to generate a full 
complement of T cells in irradiated repopulated mice is not clear. 
It might be expected that this would take longer than for B cells 
since, during ontogeny, T helper cell activity is somewhat delayed 
(Chiscon & Golub 1972). However, it is possible that the really very long 
time required for T cell recovery in radiation chimaeras is due to a 
reduced ability of the recipient thymic epithelium to effect different-
iation or maturation of these cells. Hirokawa and Makinoden (1975) 
demonstrated that the rate of recovery of T cells in irradiated 
reconstituted mice was a function of the age of the recipient thymus. 
They showed that involution of the thymus which began at 6 weeks of age 
was responsible for a progressive decline in T cell numbers and helper 
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activity under these conditions. Since the irradiated recipients of 
transplanted bone marrow were 3-6 months old some reduction in the 
ability of their thymuses to export mature T cells might be expected. 
In addition, lethal irradiation which has been shown to damage the thymic 
epithelium (Miller et al 1966) may further reduce the supply of 
functional I cells. Since GvH reactivity, a thymus dependent response 
has been shown to decline with serial transfer, it is evident that it 
becomes progressively more difficult to generate at least some classes 
of T cells from multiply..transplanted stem cells. It seems probable 
that this is also true of the classes of T cells that co-operate in the 
antibody response to both Sill and SRBC. It is not possible to state 
here whether, given time, even recipients of multiply—transplanted 
stem cells would respond normally. Experiments described in this 
chapter do demonstrate that the anti-Sill response in 'Transfer 3' mice 
increases between 10 and 20 weeks and it is conceivable that eventually 
it would recover altogether. The number of stem cells contributing 
to haematopoietic regeneration declines progressively with serial 
transfer (Ogden.& Micklem 1976). Since production of normal T cell 
numbers from even the relatively large number of cells proliferating 
in 'Transfer 1' mice (Ogden & Micklem 1976) is evidently a slow process, 
it is possible (if availability of thymic progenitors is a limiting 
factor, as suggested by Wallis et al (1975)) that the recovery of T 
cells of later transfer generations would take still longer, perhaps 
longer than the life-span of the mouse. 
Summary 
The experiments discussed in this chapter show that serial trans-
plantation of bone marrow stem cells results in a progressive decline 
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in the function of at least some classes of progeny imrnunocompetent 
cells. It appears that the cells most affected are the thymus 
dependent lymphocytes. The available evidence suggests that B cells 
are less susceptible to the effects of irradiation and reconstitution 
than T cells. A reduction in their ability to produce antibody with 
serial transfer, however, cannot be entirely ruled out. 
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CHAPTER THREE 
ACCUMULATION OF PROTEIN ERRORS 
INTRODUCTION 
It is now well established that diploid human fibroblasts 
have a finite lifespan in culture. Primary cell cultures multiply 
at a constant rate for many cell generations but finally enter a 
senescent state which culminates in the death of the culture 
(Hayflick & Moorhead 1961, Hayflick 1965). Two main theories have 
been advanced to account for this 'ageing' phenomenon, 
(i) programmed ageing, and (ii) the accumulation of genetic errors. 
Programmed Ageing 
This theory proposes that ageing is a programmed event, controlled 
either by specific 'ageing' genes which come into operation late in 
life or by the repression of adult genes (Hayflick 1973). Thus all 
developmental changes that take place during senescence can be 
attributed to a pre—existing genetic programme. Support for this theory 
comes from both in vivo and in vitro evidence. In vitro the number 
of population doublings of which a diploid fibroblast culture is 
capable is finite and relatively constant for a given species (Thomson 
& Holliday 1973, Hayflick 1973). The implication is that there exists 
some sort of clock mechanism that is able either to count the number 
of cell divisions or to measure some other recurrent or sequential 
cellular process. That biological clocks do exist in vivo is shown 
by the controlled onset of puberty and menopause. In addition, the 
death of groups of cells and whole organs, presumably genetically 
programmed, is a prominent part of embryonal development (Saunders 
1966). Two molecular mechanisms for counting cell divisions have been 
proposed. One depends on the failure to complete replications of the 
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DNA molecule at the very end of the chromosome arms, which leads to 
a progressive terminal deletion of genetic material with continuing 
cell division, and the other depends on the sequential modification 
of bases in repeated sequences of DNA by specific enzymes (Holliday 
1975). The number of divisions counted is directly related to the number 
of repeats in the sequence (Holliday & Pugh 1975). The merit of 
the molecular clock theory is that it readily accounts for transformation. 
If cells are programmed to age then a mutation that interferes with this 
programme could make them immortal. 
There is however a certain amount of evidence (reviewed by 
Holliday 1975) that suggests that the life—span of diploid 
fibroblasts at least in vitro is not related to a clock based 
on cell divisions. For example environmental changes such as 
increasing the culture temperature (Thompson & Holliday 1973) 
significantly reduced the life—span of fibroblasts without 
influencing their growth rate. That fairly simple environmental 
changes can seriously shorten life—span argues against a programmed 
control of in vitro ageing rigidly based on cell division. 
Error Theories of Ageing 
The other main theory of ageing maintains that the genetic 
apparatus does not include a programme for senescent changes - per se 
but that molecules simply accumulate inaccurate information. The loss 
of accurate or reliable information is the result of an accumulation 
of random events which damage essential information - containing 
molecules. There are two types of error theory. The somatic 
mutation theoryproposes that, during growth, genetic damage occurs 
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and that after a given number of defects have accumulated the cells 
die. Somatic mutation can only account for the limited life-span of 
fibroblast cultures if (a) there is an average of at least one defect 
per cell division which is expressed in at least half the daughter 
cells (this preventsdilution out of the mutation during growth) and 
(b) the mutations that occur initally must have no effect on 
growth rate (to prevent selection for those cells with the fewest 
mutations). The chief drawbacks of this theory are that the mutation 
frequency needs to be very high and the mutations need to occur 
initially in non-essential genes. Medvedey (1972) has attempted to 
find a way round this problem by postulating that multiple copies 
exist of all essential genes which are inactivated randomly with time. 
The second error theory of ageing as proposed by Orgel (1963, 
1970) depends on the accumulation of defects during protein synthesis. 
Thee are two steps in protein synthesis that require discrimination 
between related molecules. Firstly each activating enzyme must 
select a unique amino acid and load it onto the appropriate t-RNA; 
the codon of the m-RNA must then pair with the anti-codon of the 
appropriate, but not inappropriate, t-RNA. Errors can occur at each 
of these stages. Since the enzymes that are part of the protein 
synthetic pathway are synthesised in the same way as other cellular 
proteins, errors in such enzymes would lead to further inaccuracies 
in the next generation of proteins (including the enzymes themselves) 
synthesised. Eventuallly the error frequency will be such that the 
cell can no longer function. It is possible, however, that under 
certain conditions a protein-synthetic apparatus containing a 
relatively small numbers of errors might be able to generate a new 
protein - synthetic apparatus containing fewer errors (Orgel 1970). 
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Enzymes that scavenge error-containing proteins CGoldberg 1972) would 
assist in the maintenance of a small stable error frequency. It 
is clear as pointed out by Holliday and Tarrant (1972) that it may 
be difficult to distinguish between somatic mutation and error 
catastrophe, since somatic mutations in genes controlling protein 
synthesis would also lead to a 'catastrophic' situation. 
There exists in the literature a large amount of evidence 
that suggests a lowered ability to synthesise protein in ageing 
systems. Several reports show that in old animals a larger proportion 
of ribosomes exist as monomers (Mainwaring 1969,Wallach& Gershon 
1974). More recently Baker and Schmidt (1976) have described a 23% 
reduction in ribosomal RNA in ageingrosophi1a with an accompanying 
alteration in its structural integrity. The theory of error catastrophe 
predicts that in senescent cells, for any given enzyme, a population 
of molecules will exist with a range of catalytic activity from 
completely normal through various degrees of partial activity 
to totally inactive forms (Gershon & Gershon 1976). However the data 
available on levels of enzymes In ageing systems are confusing. The 
results are vartable depending on the laboratory, animal or tissue 
being studied. It is clear, however, that the level of the bulk of 
enzymes (80-90%) changes very little with age and few change more 
than 25% (Finch 1972, Wilson 1973). Analysis of enzymic acitivity is 
complicated by the uncertainty as to whether activity measured in vitro 
presents an accurate reflection of biological processes in vivo. In 
addition as has been pointed out by Florini (1975) the absence of 
noticeable age related changes could result from selection, since 
studies of animals near their mean life-span must necessarily deal 
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with the 50% that have survived. Selection of particular species 
of enzyme may also occur during extraction procedures (Wilson & 
Frank 1975). However, that enzyme levels remain stable or even increase 
in old age is not necessarily indicative of an error-free protein 
synthetic machinery. It is probable that a loss of activity, particularly 
of those enzymes whose activity is essential for the maintenance of 
viability and whose levels are likely to be strictly regulated may be 
compensated for by increased protein production. The activity of 
glucose-6-phosphate dehydrogenase (G6PD) increases with age both 
in vivo (Wilson 1973) and in vitro (Fulder & Tarrant 1975). Fulder 
and Tarrant (1975) suggest that the increased activity may be due 
to errors in enzymes responsible for protein degradation. Alternatively, 
errors in regulator gene products, resonsible for gene repression, 
could result in de-repression of genes and thus increased enzyme 
production. 
It is evident that methods more sensitive than the mere 
measurement of overall activity are required to detect altered 
enzymes. Gershon and Gershon (1970) demonstrated an age related 
accuniulation,in neniatodes,of an enzyniically inactive material 
antigenically cross reactive with isocitrate lyase (CRM). In addition 
a greater percentage of the enzyme from old (35 days) animals was rapidly 
inactivated at 45° C. As the heat inactivation curves for 'young' 
and 'old' enzyme were parallel between 5 and 16 minutes it was 
concluded that the isocitrate lyase in old animals consisted of a 
mixture of active and inactive enzymes. Similar results were obtained 
for nematode aldolase (Zeelon et al 1973). Since a mixture of young' 
and 'old' homogenates yielded the expected additive results the 
presence of enzyme inhibitors in old homogenates is unlikely. The CRM 
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and the labile fraction represent altered protein. Defective 
protein molecules have been described in Neurospora (Lewis & 
Holliday 1970) and fungi (Holliday 1969). Holliday and Tarrant 
(1972) have shown that senescent human fibroblast cultures have 
an increased proportion of heat—labile G6PD and 6-phosphogluconate 
dehydrogenase. In addition, the increase in heat lability was 
shown to correlate with an increased proportion of enzyme able to 
utilize an analogue substrate, a characteristic of many naturally 
occurring mutants. Fibroblasts from patients with Werners syndrome 
a disease associated with premature ageing, which are unable to survive 
in culture beyond 2-3 doublings, had an increased proportion of heat—
labile G6PD at a given passage, compared with fibroblasts from a normal 
donor (Holliday et al 1974). Similar increases in altered enzymes 
have been discerned in ageing mammals. Gershon and Gershon (1973a, 
1973b) found an increase in mouse muscle aldolase and mouse liver 
aldolase CRM in old animals. Wulf and Culter (1975) found an increase 
in the heat-labile fraction of G6PD in a range of tissues from old 
mice. Age related changes in rabbit liver aldolase (Anderson 1974), 
rat liver lactic dehydrogenase (Shapira et a] 1975) and rat membrane 
bound microsomal and mitochondrial enzymes (C-rinna & Barber 1972, 
Gold & Widnell 1974) have also been described. 
If ageing is due to an accumulation of errors in protein synthesis 
then agents that directly and indirectly introduce mistakes in transcrip-
tion and translation should induce premature senescence. Holliday and 
Tarrant (1972) found that the addition of the base analogue 5-fluor-
ouracil (which is incorporated in to RNA and introduces errors in 
transcription and translation) to fibroblast cultures, severely reduces 
their in vitro life-span. Similarly Harrison and Holliday (1967) and 
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more recently Holliday and Stevens (1978) have shown that low 
concentrations of the amino acid (phenylalinine) analogue, 
p-fluorophenylalinine, fed to rosophila rielanogaster and CBA mice 
significantly shortens their life-span. While the authors do not 
regard experiments with amino acid analogues as an adequate test of 
the protein error theory of ageing, they add weight to the general 
hypothesis that ageing is in some way related to protein structure. 
Any errors in proteins involved in the multiplication and 
transcription of nucleic acids will greatly increase the error 
frequency in ageing cells. Chromosomal abnormalities significantly 
increase inthe final phase of fibroblast cultures (Thomson & 
Holliday 1975). Various modifications of DNA associated proteins 
(e.g. histones) occur during senescence (Von Hahn 1966, Stein 1975, 
Maizel et al 1975). In addition altered DNA and RNA polymerases 
have been described in senescent systems both in vivo (Bolla & Brot 
1975) and in vitro (Linn et al 1976). The enzymes involved in DNA 
repair mechanisms are of particular importance. Epstein et al (1974) 
and Mattern and Cerutti (1975) have presented evidence that DNA 
repair mechanisms in vitro in senescent human fibroblasts cultures 
are reduced. The ability to repair damaged DNA may be related to the 
life-span of thespecies (Hart & Setlow 1974). Thus, while ageing may 
be caused primarily by a non-programmed accumulation of protein 
errors it is clear that the extent to which cells can withstand 
error-induced damage will be under genetic influence. 
The finite life-span of haeinatopoietic stem cells in vivo under 
conditions of serial transfer, is in some ways analagous to the 
senescence of in vivo fibroblast cultures. It seemed possible, therefore, 
that the decline in regenerative potential of serially-transplanted stem 
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cells might be accompanied by an accumulation of protein errors. 
It is not possible to isolate haematopoietic stem cells, but errors in 
parental cells should be transmitted to their descendants. Erythroc-
ytes, produced in large numbers and easily isolated as a relatively 
pure population, were the descendant cells of choice. In addition, 
they possess relatively large concentrations of glucose-6-phosphate 
dehydrogenase (G6PO) an enzyme that has been used extensively in 
estimates of protein errors in ageing systems (Holliday & Tarrant 1972, 
Wulf & Culter 1975, Pendergrass et al 1976). G6PD is the 
initial enzyme in the hexose monophosphate shunt. It utilises 
glucose-6-phosphate as a substrate and is measured by the reduction 
of NADP to NADPH. NADPH is required for the production of 
glutathione which is necessary for the maintenance of the cell's 
proper redox potential. The thermolability of G6PD seems to be a 
fairly sensitive probe for amino acid substitutions since of 61 human 
G6PD mutants tested, 29 are thermolabile (Wulf & Culter 1975). 
In order to detect a few per cent of heat labile enzyme it is 
necessary to use an enzyme that is normally homogeneous and which there-
fore loses activity exponentially during heat treatment, (mixtures 
of isozynles would not be expected to decay exponentially: Holliday & 
Tarrant 1972, Wulf & Cutler 1975). In addition, an accurate assay is 
essential. Murine erythrocyte G6PD seems to fulfil both these 
criteria. 
The assay medium included both excess of NADP and the reducing 
agent 2-rnecaptoethanol (2!1E) both of which influence the G6PD stability 
(Wulf & Cutler 1975). The thermostability enzyme assay to detect 
altered protein, requires the altered protein to retain activity at 
the control temperature. As a consequence, the sensitivity of the 
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aia.5to detect all altered enzyme decreases as enzymic activity 
is lost. For this reason control samples were kept at 25 ° C and the 
assays of enzyme activity were carried out at the same temperature. 
To determine the fraction of heat—labile enzyme it is essential 
to measure, as accurately as possible, the activity before heat 
treatment. For this reason unheated enzyme samples were assayed 
in triplicate. 
The heat lability of G6PD increases with the age of the 
erythrocyte (Fournaini 1969). This modification of the enzyme 
is a post-translational event. It was therefore necessary to 
measure its activity in young erythrocytes. Preparations consisting 
predominantly (60-80%) of reticulocytes were made by treatment of mice 
with phenylhydrazine. Phenyihydrazine induced red cell lysis possibly 
by inducing potassium loss (Prankerd 1963). Large numbers of 
reticulocytes are released in to the circulation to make up for this. 
The main problem in using erythrocyte G6PD for heat stability 
experiments was that, at the inactivation temperature used (52.4 °C) 
haemoglobin denatured thus obscuring spectrophotometer readings. It 
was therefore necessary partially to purify the enzyme so as to remove 
most of the haemoglobin. 6-phosphogluconate dehydrogenase is another 
enzyme, in the same pathway as G6PD, whose activity is measured by the 
formation of NADPH. Holliday and Tarrant (1972) and Wulf and Cutler 
(1975) found that this enzyme made a negligible contribution to the 
amount of NADPH formed when glucose-6-phosphate was used as a substrate. 
It is assumed therefore that increase in 00 at 340nm, measured only 
NADPH formed by the activity of G6PD. 
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MATERIALS AND METHODS 
Mice, preparation of cell suspensions, irradiation and serial 
transplantation of bone marrow cells were all as described in 
Chapter 1 
Preparation and assay of Glucose-6-phosphate dehydrogenase (G-6-PD) 
from mouse reticulocytes 
Induction of reticulcytosis 
Reticulocytosis was induced in mice by the intra-peritoneal (IP) 
L. 
injection of neutralised phenydrazine hydrochloride (Sigma 
Chemical Co.,, London) at a dose 1mg/mouse/day for 3 days (Hodgson, 
Bradley & Tel fer 1972). The solution of phenyihydrazine was made up 
fresh every day in distilled water and adjusted to pH7.0 with NaOH. 
ReticulQcytes were stained with 1% New Methylene Blue; lg New 
Methylene Blue (Raymond A. Lamb, London) dissolved in lOOmi of citrate 
saline (1 volume of 30g/litre sodium citrate to 4 volumes 9.0g/litre 
sodium chloride) filtered before use. One volume of the dye was 
mixed with 2-4 volumes of blood and incubated at 37 ° C for 15-20 
minutes. Reticulocytes were enumerated from a wet preparation. 
Partial purification of G6PD 
Peak reticulocytosis was achieved on day 7 (see results). The 
mice were bled, at this time, from the retro-orbital plexus into 
heparinised saline. The red cells were washed 3 times in cold saline. 
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After the final wash the supernatant was discarded and the packed 
cells resuspended in 9 volumes of the red blood cell lysing solution 
(see Appendix). The lysate was spun at 20,000g for 1 hour to remove 
red ce ll ghosts. 
The G6PD in the supernate was roughly purified by the method 
described by Hutton (1971). This procedure removed most of the 
haemoglobin. Saturated ammonium sulphate (SAS) was added drop-wise 
to the supernate, which was agitated on a magnetic stirrer, to bring 
the final concentration to 45% saturation, and stood on ice for 
30-60 minutes. The mixture was then centrifuged on a MSE6L for 30 
minutes at 5000g at 4 °C. The precipitate was discarded and the supernate 
brought to 75 0/0' saturation with more SAS and stood on ice for a 
further 30-60 minutes. After centrifugation for 30 minutes at 5000g 
the supernatant was discarded and the pellet washed twice in 80% SAS 
and dissolved in extraction buffer (Appendix). The enzyme was dialysed 
against several changes of extraction buffer and stored in lml 
aliquots at -60°C. No sample was frozen more than once. This 
extraction procedure resulted in a loss of approximately 30% of 
G6PD activity. 
Assay of G6PD Activity 
G6PD activity was measured by modification of the assay described 
by Körnberg and Horecker (1955). The enzyme sample was diluted 1 in 20 
in extraction buffer. 0.lml of the enzyme was added to lml of assay 
buffer (see Appendix) in a tube and mixed by shaking. The tube was 
then incubated at 25 ° C for 15-20 minutes. 0.5ml of each of 0.lM EDTA 
and 100% methanol were added at the end of this time to stop the reaction. 
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The absorbance at 340rirn was read on a Hitachi spectrophotmeter using 
the tungsten lamp against a blank of assay buffer plus EDTSA and 
methanol. Pooled cells from 3 mice were used for each sample of the 
enzyme. 
Heat inactivation 
O.lml samples of G6PD were put into glass test-tubes. The tubes 
were capped to prevent evaporation and incubated in a water bath 
maintained at the required temperature. At intervals the tubes were 
removed from the water bath and cooled rapidly on ice. The sample 
was then assayed for surviving activity. Unheated controls, 
maintained at 25 ° C, were set up in triplicate. Inactivation was 
usually followed for 30-40 minutes. The results were expressed as 
the per cent remaining activity plotted on a semi-log scale versus 
time. The linear portion of the curve was extrapolated to zero and the 
fraction of thermolabile enzyme determined. 
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RESULTS 
The reticulocytosis induced by three daily injections of phenyl-
hydrazine, peaked on days 7-8 (Fig 3.1). In all experiments the 
mice were bl2d on day 7. The enzyme was roughly purified by 
precipitation with saturated ammonium sulphate which removed most 
of the haemoglobin. About 70% of the original activity was recovered. 
The kinetics of enzyme activity measured by the increase in 00 
at 340nm were linear (Fig 3.2). Similarly the increase in 00 with 
increasing concentrations of enzyme (at least for the enzyme 
concentrations used in these experiments) were also linear (Fig 3.3). 
The linearity of the kinetics of the activity of G6PD was confirmed 
using a recording spectrophotometer. 
The kinetics of thermal inactivation of the enzyme from normal 
donors were determined for a range of temperatures (Fig 3.4). G6PD 
lost its activity exponentially during heat treatment confirming 
the homogeneity of this enzyme. A small increase in temperature 
resulted in a marked decrease in activity. 52.4 ° C gave a suitable 
rate of inactivation and was used in all subsequent experiments. 
Phenyihydrazine, which was used to induce reticulocytosis, is 
an oxidising agent. It was conceivable that G6PD, whose stability 
is known to be influenced by environmental factors (Wulf & Culter 
1975) ,may have had a greater proportion of heat labile enzyme when 
it was derived from phenylhydrazine injected mice than when it was 
derived from normal mice. The heat inactivation curves of G6PD 
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Fig. 3.1 The number of reticulocy-bes expressed as 	in the 
peripheral blood of normal mice, at intervals after 3 daily doses of 
phenyihydrazine (1 mg/mouse/day) i.p. Each point represents the mean 
value for 5 mice. 
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Fig. 3.2 The increase in /VADPH with incubation time of a sample 
of reticulocyte G6PD from phenyihydrazine treated mice (3 daily doses 
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Fig. 3.3 The activity of varying concentrations of a sample of 
reticulocyte G6P]J from phenylbydrazine treated mice (3 daily doses 
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Fig. 3.4 The thermal inactivation (expressed as % remaining activity) 
of reticulocyte G6PD from phenyihydrazine treated mice at 50.10C ( 0 ), 
52.40C ( • ) and 53.30C ( 	). Mice received 1 mg phenylhydrazine/ 
mouse/day for 3 days and were bled on day 6. Pooled G6PD from 
3 donors was assayed. 
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from the erythrocytes of mice which had received one injection 
of phenylhydrazine (1mg/mouse) 24 hours previously (Fig 3.5a). 
Approximately 15% of the enzyme was labile at this temperature for 
both groups. Thus this dose of phenylhydrazine did not influence 
the heat stability of the enzyme. Fig 3.5b shows the heat 
inactivation curve of 2 further samples of G6PD extracted from 
the pooled blood of untreated intact mice. Erthrocytes from mice 
that had not received the 3 daily injections of phenylhydrazine 
consistently yielded an enzyme 15-20% of which was labile at 52.4 ° C. 
In contrast G6PD from the reticulocyte rich blood of phenylhydrazine 
treated mice that consisted of 60-80% reticulocytes had a heat 
labile fraction of 5-10% (Fig 3.6); a value that accords well with the 
5% heat labile G6PD detected in young fibroblasts (Pendergrass et al 
1976) and was possibly due to a small percentage of altered enzyme. 
This result suggests that at least 10% of the heat labile enzyme seen 
in the erythrocytes of normal mice is due to post translational 
modification. 
G6PD from reticulocytes of recipients of serially transplanted bone 
marrow stem cells (pooled reticulocytes from 3 donors) were heat 
inactivated at 52.4° C. Bone marrow transplantation had taken place 
at least 8 weeks previously. Enzyme from recipients of once, twice, 
three and five times transplanted bone marrow was compared with that 
from normal animals (Fig 3.6). The results were repeatable for the 
same enzyme preparation. At least three different preparations were 
tested for each transfer generation. The results shown in Fig. 6 
are representative. No increase in heat lability could be detected 
between G6PD from reticulocytes descended from normal stem cells and 
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Fig. 3.5 The thermal inactivation at 52.40C (expressed as 
remaining activity) of G6FD from the erythrocytes of normal and 
phenyihydrazine treated mice, a) normal mice ( • ); mice which 
had received 1 mg of phenyihydrazine 24 hours previously ( 0 ); 
b) 2 samples of G6PD from normal mice ( • , 0 ). Each sample 
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Fig. 3.6 The thermal inactivation at 52.40 C (expressed as % remaining 
activity) of G6PD fran the reticulocytes of normal mice and irradiated mice 
reconstituted with serially transplanted bone marrow 8 weeks previously. 
Mice received 3 doses of phenylbydrazine at 1 mg/mouse/day and were bled 
on day '. Each sample represents pooled enzyme from 3 donors. a) normal 
mice ( • ); 'Transfer 1' mice ( 0 ). 	b) normal mice ( • ) 
'Transfer 2' mice ( 0 ). 	c), normal mice ( • ); 'Transfer 3? mice 
( 0). 	d) normal mice ( • ); 'Transfer 5 1 mice ( (D ). 
transplanted up to five times. A slight difference in the rate 
of inactivation of the enzyme was seen from experiment to experiment. 
This does not influence the proportion of heat labile enzyme and was 
probably due to fluctuations in the temperature of the water bath 
since a small increase in temperature resulted in a marked increase 
in the rate of inactivation (Fig 3.4). 
In conclusion, the 'senescent' state induced in haematopoietic 
stem cells by serial transplantation, was not accompanied by an 




It has beenproposed by a number of authors (Orgel 1970, 
Holliday & Tarrant 1972) that the accumulation of errors in protein 
may be one of the primary causes of ageing, and indeed, altered 
protein appearsto be a widespread phenomenon both in vivo 
and in vitro ageing systems. Haematopoietic stem cells under 
conditions of serial transplantation, exhibit a finite lifespan 
analogous to that seen in populations of diploid fibroblast 
maintained in cultures. Altered proteins have been detected in 
senescent fibroblast cultures by several workers (Holliday & 
Tarrant 1972, Linn et al 1976). However, attempts to detect 
altered proteins in reticulocytes derived from serially transplanted 
haematopoietic stem cells, by measuring the heat labile fraction 
of G6PD, failed to show any increase in heat lability with 
transfer. There are three possible explanations for this result: 
That 'error catastrophe' is not a primary cause of ageing. 
That 'error catastrophe' does occur in ageing cells but 
that serial transfer does not mimic a normal ageing situation. 
That an accumulation of protein erors does occur in serially 
transferred haematopoietic stem cells but that for some reason 
they were not detectable in erythroid cells by the techniques 
used. 
There now exists a fairly extensive literature that suggests that 
the accumulation of altered proteins in ageing cells is not a universal 
phenomenon. 
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(a) Danot et al (1975) found no altered aldolase in senescent 
mouse fibroblast cultures. 
Kahn et al (1977) found no difference between young and 
senescent cultures in the electro-focusing patterns or the 
heat lability of 4 enzymes in human liver. 
In direct contrast to Holliday and Tarrant (1972) 
Pendergrass et al (1976) found no increase in the heat labile 
fraction of G6PD in senescent human fibroblast cultures and were 
unable to detect any increase in CR11. 
Oliveira and Pfunderer et al (1973) found no change in the 
ratio of enzyme:antigen as a function of age for lactate 
dehydrogenase in ageing mice. 
Wilson et al (1978) could detect no change in the size or 
charge of proteins from the sympathetic ganglia of young and 
old rats. 
Steinhagen-Thiessen and Hilz (1976) showed that age-dependent 
decreases in the level of creatine kinase and aldolase in human 
striated muscle were not due to an accumulation of faulty proteins. 
Thus it is evident that the question of whether ageing is 
accompanied by an accumulation of altered proteins is by no means 
settled. The experimental system used and the choice of tissue may 
influence the results. Grinna and Barber (1975) have demonstrated 
an increase in the heat labile fraction of rat liver G6PD with age. 
However, if kidney G6PD is tested the proportion of labile enzyme 
decreases with age. Environmental factors that influence the 
stability of proteins must also be taken into consideration. For 
example, the stability of G6PD has been shown to depend on the presence 
of NADP (Wulf & Culter 1975). Thus, suboptimal concentrations 
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of NADP, or indeed the presence of enzymes that split NADP such 
as NADP glucohydrogenase, may erroneously suggest an increase 
in altered enzyme. Kahn et al (1977) claim that intracellular 
factors may be responsible, at least in part, for the increased heat 
lability of enzymes from old cells. They found that after partial 
purification, G6PD from young and old cells showed a similar 
stability. They considered that this was not due to the loss of 
the heat labile fraction during purification, since 90% of the 
activity was recovered. Thus, it appeared that the difference 
in heat lability found in cells of different ages was not due to 
structural changes of the enzyme but rather to environmental 
changes. The experiments described here used partially purified 
enzyme, which may explain the absence of altered enzyme in the cells 
tested. There are also objections to the use of disrupted cells and 
tissues for heat stability studies. An increase in lysosomal 
enzyme activity as a function of age, has been reported both in vivo 
(Elens & Walliaux 1969) and in vitro (Cristofalo et al 1967). 
It is possible that the increase in heat labile enzyme observed 
in many systems, may simply be the result of 1yssoma1a.niage. Some 
support for this concept comes from Helfman and Price (1974) who could 
detect no increase in heat—labile x-amylase, in the saliva of ageing 
humans where cellular disruption was avoided. 
A major consideration to be borne in mind when analysing 
experiments of the sort described here, is the relative rates of 
protein synthesis and degradation (Lewis 1972). Most abnormalities 
found in the proteins of ageing cells could be ascribed 
to alterations of the protein molecule after its biosynthesis, 
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i.e. post-translational modifications. There are data which suggest 
that post-translational modifications of protein does occur. 
In erythrocytes post-translational modifications have been 
described for G6PD (Fournaini et al 1969), pyruvate kinase 
(Paglin et al 1970) and aspartate amino transferase (Fisher & 
Walters 1971). In addition, Gallop and Paz (1965) have described 
post-translational modifications of collagen and elastin. Shapira 
et al (1975) found a higher ratio of enzyme activity to antigen in the 
liver of young rats than old rats. After partial hepatectomy of 
old rats, however, the newly generated liver produced enzyme with 
approximately double the original specific activity. Thus the new 
liver cells in old animals did not produce altered enzyme suggesting 
that the accumulation of inactive enzyme in old rats was a post mitotic 
event. Cultures of senescent fibroblasts include a significant 
proportion of dead and dying cells (Lewis & Tarrant 1972). 
Approximately 50% of the cells in late passas are non-dividing 
(Merz & Ross 1969). It may therefore be that the altered proteins 
detected by some workers in senescent fibroblast cultures are the result 
of post-translational modifications in non-dividing fibroblasts. 
The reason for the accumulation of post-translational modifications 
in ageing cells presumably has to do with the rate of protein 
turnover. Young et al (1975) and Maciera-Coelho et al (1966) have 
described a reduced rate of protein synthesis in old cells. If both 
protein synthesis and breakdown are slowed then the half life of the 
proteins and opportunity for kinetic or metabolic modification of the 
protein will increase (Rothstein 1975). It should be noted, 
however, that post-translationalmodifications of enzymes involved 
in protein synthesis, and indeed nucleic acid replication or 
transcription, would act to introduce errors into the next 
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generation of proteins and may thus initiate an 'error catastrophe'. 
There is now considerable evidence that proteins which are 
altered in some way are degraded more rapidly in vivo than. their 
normal counterparts (Goldschmidt 1970, Stevens and Sauberlich 1970). 
Starvation, which presumably leads to substantial protein degradation 
has been shown to reduce the levels of altered protein in old animals 
(Ogrodnik, Wulf & Culter 1975). Thus, a lack of altered protein 
in ageing animals mightreflect rapid degradation rather than a failure 
to synthesise faulty proteins. 
There is one piece of evidence that argues particularly strongly 
against the accumulation of errors at the level of translation in 
ageing cells. Holland et al (1973) and Tomkins et al (1974) 
reported that when old cells were injected with RNA and DNA viruses, 
the viruses produced were as viable as those grown in young cells. 
The thermostability and mutation frequency of viruses from old cells 
were also unaltered. Since viruses use the enzymic machinery of 
the host cell, such experiments would seem to argue against the 
presence of damaged transcriptional or translational processes in 
senescent cells. However it is possible, as pointed out by Holland 
et al (1973), that either the errors in old cells were restricted 
or that the viruses had evolved so as to be able to replicate and 
mature in spite of translational errors. 
It is clear therefore that the viability of an 'error 
catastrophe' theory of ageing, at least as a major cause of ageing, 
is still in question. It may well be that the failure to detect 
altered G6PD, in reticulocytes derived from multiply transplanted 
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haematopoietic stem cells, adds some weight to the arguments that are 
in opposition to 'error-catastrophe'. On the other hand, it is 
probable that serial transfer fails to mimic true ageing processes 
and thus no accumulation of protein errors would be expected. The 
dilution out of rare cell populations and the disruption of the 
haematopoietic microenvironment, not to mention the differential 
sensitivity of bone marrow haematopoietic stem cells to mitotic 
stimulus, described in Chapter I, all suggested that serial transfer 
cannot be regarded as a way of accelerating the normal ageing of 
haematopoietic stem cells. The evidence presented in Chapter I, 
suggested that the general haematopoietic decline observed during 
serial transfer, was due to the stem cell population consisting of 
fewer and fewer fairly 'powerful' cells and more and more non-
renewing cells. On subsequent transfer, it is the few 'powerful' 
stem cells that make the major contribution to haematopoietic regen- 
eration (Ogden & Micklem 1976). It is probable that the reticulocytes 
manufactured following phenylhydrazine treatment, were generated from 
these relatively normal 'young' stem cells which had not as yet 
accumulated many translational errors. Descendant reti cul ocytes 
would therefore possess unaltered G6PD. 
There are, however, 2 alternative explanations for the results 
achieved here. Firstly, erythroid progenitors that possess errors 
in their protein synthetic machinery generate only very small clones 
of cells and thus go undetected. Secondly, it is possible that 
serial transfer of haematopoietic stem cells did lead to increased 
fractions of heat labile G6PD in descendant reticulocytes but that 




In this study we were unable to demonstrate a finite life-span 
for haematopoietic stem cells induced to regenerate repeatedly 
in situ. Thus, the decline in stem cell activity seen in serially 
transplanted and cultured bone marrow was very probably a consequence 
of the experimental techniques employed, rather than a direct result 
of an increasing mitotic burden. The data were consistent with 
progressively fewer relatively 'good' stem cells regenerating 
haematopoietis after each bone marrow transfer. The loss of 'good' 
stem cells possibly by dilution, resulted in a reduction in (a) the 
overall marrow stem cell function, and (b) the immune-responsiveness 
of irradiated repopulated mice. 
These experiments failed to demonstrate that under normal 
conditions haematopoietic stem cells in vivo were subject to a 
Hayflick limit. Recent work by Hamilton (1978) suggests that this 
may be true of the stem cells of other renewing systems. She was 
unable to detect any loss of proliferative capacity in the stem cells 
of the gut, either with normal ageing or by artificially inducing 
repeated regeneration in situ. it is clear, therefore, that 
extrapolation from events in in vitro fibroblast systems to 
predictions regarding normal ageing in intact organisms must be 
regarded with caution. 
Recently Kirkwood and Holliday (1975) have suggested that the 
finite life-span of fibroblasts in culture may also be an experimental 
artifact. They have proposed a theory of cellular 'ageing' that 
invests a sub-population of fibroblasts with stem cell-like properties 
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These 'uncommited' cells are themselves considered to be capable of 
indefinite multiplication, but they have a certain probability (p) of 
irreversible commitment to senescence and death. Such cells, depending 
on the size of the cultures and the value of p, are vulnerable to 
dilution in a way analagous to the suggested loss of powerful 
haematopoietic stem cells during serial transplantation. Several 
predictions of this 'colTillitment theory of cellular ageing' have 
now been supported by experimental results (Holliday et al 1977). It 
is particularly interesting that results of Zavala, Fialkow and 
Herner (quoted by Holliday et al 1977) show that, like haematopoietic 
regeneration following serial transfer (Ogden & Micklem 1976), ageing 
fibroblast cultures are probably generated from fewer and fewer clones. 
The aim of this study was to evaluate serial transfer as an in vivo 
analogue of the Hayflick cellular ageing system. We conclude that 
while the limited life-span of serially transplanted tissue does indeed 
appear to mimic in vivo, serial subculture of fibroblasts in vitro, 





10 x concentrated 
Dextrose 	 10.Og 
KH 2 PO4 	 0.6g 
Na2 HPO 4 .12H2 0 	 4..78g 
Phenol red 	 20.0ul 
+ 980ml distilled water 
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Solution B 
10 x concentrated 
CaC1 2 .2H 2 0 1.86g 
KC1 4.Og 
NaCl 80.Og 
MgCl 2 .6H 2 0 2.Og 
MgSO 4 .7H 20 2.Og 
+ 1 litre distilled water 
For use 
lOmi solution A + lOml solution B + 80m1 distilled water 
Phosphate Buffered Saline 	(PBS) p1-17.2 
O.86g 
Na2 1-1PO 4 .l2H2 0 	 5.69g 	+ 1 litre distilled water 
NaCl 	 5.67 
O'Mearas Medium 
Solution A (adjusted to pH8.0) 
Difcose proteose-peptone 	 lO.Og 
Oxoid bacto-peptone 	 40.Og 	+ 900ml distilled water 
NaCl 	 5.Og 
Glucose 	 5.Og 
NaHCO 3 	 5.Og 	+ lOOml distilled water 
K2HPO4 	 2.Og 
Add solution B to solution A and sterilize by filtration 
Add Thyoglycollic acid to give a final concentration of 0.01% 
immediately before use 
G6PD Extraction Buffer 
1 x 10 3M 
7 x io 
9 x 10 -4 M 
5mg crystalline 






G6PD Assay Buffer 
1 x 10 -2 M 
	
Glucose-6-phosphate 
2 x 10 2M 
	
MgCi 2 




Made up in 0.25M 	TRIS-HC1 (pH8.6) 
Red Cell Lysing Solution 
7mM 	-Mercaptoethal 
10 M NAD 
Made up in distilled water 
9 Vols. of the above was added to 1 Vol. of packed red cells and 
stirred for 10 minutes on ice. 
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